RxNorm Semantic Concepts Index - 154
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "154".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 154 | Nicoumalone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 154 | Nicoumalone | Designated preferred name (PT) | NO | |
| RxCUI: 154 | Nicoumalone | Full form of descriptor (FN) | NO | |
| RxCUI: 154 | Nicoumalone | Designated preferred name (PT) | NO | |
| RxCUI: 154 | Nicoumalone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154 | Nicoumalone | Full form of descriptor (FN) | NO | |
| RxCUI: 1540 | bile salts | Designated preferred name (PT) | NO | |
| RxCUI: 1540 | bile salts | Full form of descriptor (FN) | NO | |
| RxCUI: 1540 | bile salts | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540019 | Broncomar Expectorant | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1540020 | guaiFENesin 20 MG/ML [Broncomar Expectorant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540020 | guaiFENesin 20 MG/ML [Broncomar Expectorant] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1540021 | guaiFENesin Oral Solution [Broncomar Expectorant] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1540021 | guaiFENesin Oral Solution [Broncomar Expectorant] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1540022 | Broncomar Expectorant Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540023 | Broncomar Expectorant Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540024 | Broncomar SF Expectorant 100 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540024 | Broncomar SF Expectorant 100 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540024 | Broncomar SF Expectorant 100 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1540024 | Broncomar SF Expectorant 100 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1540025 | Eucalyptus camaldulensis leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540026 | Lincobac | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1540027 | lincomycin 300 MG/ML [Lincobac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540028 | lincomycin Injectable Solution [Lincobac] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1540029 | Lincobac Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540030 | lincomycin 300 MG/ML Injectable Solution [Lincobac] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540030 | lincomycin 300 MG/ML Injectable Solution [Lincobac] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1540045 | tiludronic acid 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1540046 | tiludronic acid Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1540047 | tiludronic acid Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1540048 | tiludronic acid 20 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540048 | tiludronic acid 20 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1540049 | tiludronic acid 20 MG/ML [Tildren] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540050 | tiludronic acid Injectable Solution [Tildren] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1540051 | Tildren 20 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540051 | Tildren 20 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540051 | Tildren 20 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540051 | Tildren 20 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1540206 | Quellin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1540207 | carprofen 100 MG [Quellin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540208 | carprofen Chewable Tablet [Quellin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1540209 | Quellin Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540210 | Quellin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540211 | Quellin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540212 | quellin 100 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1540212 | quellin 100 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540212 | quellin 100 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540213 | carprofen 25 MG [Quellin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540214 | quellin 25 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1540214 | quellin 25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540214 | quellin 25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540215 | carprofen 75 MG [Quellin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540216 | quellin 75 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1540216 | quellin 75 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540216 | quellin 75 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540219 | Fungazoil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1540220 | clotrimazole 10 MG/ML [Fungazoil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540221 | clotrimazole Topical Solution [Fungazoil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1540222 | Fungazoil Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540223 | FungaZoil 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1540223 | FungaZoil 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540223 | FungaZoil 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540223 | FungaZoil 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540225 | ketorolac 2.88 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1540226 | phenylephrine 10.16 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1540229 | Product containing ketorolac and phenylephrine (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1540229 | Product containing ketorolac and phenylephrine (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 1540229 | Product containing ketorolac and phenylephrine (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 1540230 | phenylephrine 1 % / ketorolac 0.3 % Concentrate for Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1540230 | phenylephrine 1 % / ketorolac 0.3 % Concentrate for Ophthalmic Irrigation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1540230 | phenylephrine 1 % / ketorolac 0.3 % Concentrate for Ophthalmic Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1540231 | Omidria | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1540232 | ketorolac 2.88 MG/ML / phenylephrine 10.16 MG/ML [Omidria] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1540235 | OMIDRIA 1 % / 0.3 % Concentrate for Ophthalmic Irrigation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1540235 | OMIDRIA 1 % / 0.3 % Concentrate for Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1540235 | OMIDRIA 1 % / 0.3 % Concentrate for Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1540235 | OMIDRIA 1 % / 0.3 % Concentrate for Ophthalmic Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1540238 | Brassica rapa subsp. rapa seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540239 | Lavandula stoechas whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1540240 | Vaccinium angustifolium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540241 | clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1540241 | clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1540241 | clindamycin phosphate 1.2 % / benzoyl peroxide 5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1540242 | Neuac | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1540243 | benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG [Neuac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1540244 | benzoyl peroxide / clindamycin Topical Gel [Neuac] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1540245 | Neuac Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1540246 | Neuac 1.2 % / 5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1540246 | Neuac 1.2 % / 5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1540246 | Neuac 1.2 % / 5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1540273 | PEG-10 glyceryl triisostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540274 | Olay Fresh Effects Clear Skin Spot Zinger | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1540275 | salicylic acid 20 MG/ML [Olay Fresh Effects Clear Skin Spot Zinger] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540276 | salicylic acid Topical Lotion [Olay Fresh Effects Clear Skin Spot Zinger] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1540277 | Olay Fresh Effects Clear Skin Spot Zinger Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540278 | Olay fresh effects SPOT ZINGER 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540278 | Olay fresh effects SPOT ZINGER 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540278 | Olay fresh effects SPOT ZINGER 2 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540278 | Olay fresh effects SPOT ZINGER 2 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1540332 | hydrocortisone Topical Cream [Proctosol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1540333 | Proctosol Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1540336 | Baclezene | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1540337 | neomycin 5 MG/ML [Baclezene] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540338 | neomycin Topical Cream [Baclezene] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1540339 | Baclezene Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540340 | Baclezene 5 MG/ML Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540340 | Baclezene 5 MG/ML Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540340 | Baclezene 5 MG/ML Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540340 | Baclezene 5 MG/ML Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1540356 | Proctosol-HC 2.5 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1540356 | Proctosol-HC 2.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1540356 | Proctosol-HC 2.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1540356 | Proctosol-HC 2.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1540357 | peanut oil, hydrogenated | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540358 | petrolatum 0.67 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1540359 | petrolatum 67 % / zinc oxide 13 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1540359 | petrolatum 67 % / zinc oxide 13 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540359 | petrolatum 67 % / zinc oxide 13 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540359 | petrolatum 67 % / zinc oxide 13 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540360 | hypromellose 17 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1540361 | hypromellose 1.7 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1540361 | hypromellose 1.7 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1540361 | hypromellose 1.7 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1540452 | Powder for Nasal Solution | Dose Form (DF) | YES | |
| RxCUI: 1540453 | Granules for Oral Solution | Dose Form (DF) | YES | |
| RxCUI: 1540454 | Granules for Oral Suspension | Dose Form (DF) | YES | |
| RxCUI: 1540455 | Powder for Oral Solution | Dose Form (DF) | YES | |
| RxCUI: 1540456 | Powder for Oral Suspension | Dose Form (DF) | YES | |
| RxCUI: 1540496 | salicyloyl phytosphingosine Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1540497 | salicyloyl phytosphingosine Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1540498 | salicyloyl phytosphingosine 0.02 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540498 | salicyloyl phytosphingosine 0.02 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540498 | salicyloyl phytosphingosine 0.02 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1540499 | capsaicin 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1540500 | capsaicin 0.2 % / menthol 12 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540500 | capsaicin 0.2 % / menthol 12 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540500 | capsaicin 0.2 % / menthol 12 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1540501 | Soothanol X2 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1540502 | capsaicin 2 MG/ML / menthol 120 MG/ML [Soothanol X2] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540503 | capsaicin / menthol Topical Solution [Soothanol X2] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1540504 | Soothanol X2 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540505 | SOOTHANOL X2 0.2 % / 12 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1540505 | SOOTHANOL X2 0.2 % / 12 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540505 | SOOTHANOL X2 0.2 % / 12 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540507 | acetaminophen 80 MG / chlorpheniramine maleate 0.5 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540507 | acetaminophen 80 MG / chlorpheniramine maleate 0.5 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1540507 | acetaminophen 80 MG / chlorpheniramine maleate 0.5 MG / phenylephrine HCl 1.25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540523 | ethylbenzene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540524 | aluminum hydride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540525 | aminoethylphosphinic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540526 | edetate dipotassium anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1540658 | allantoin 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1540659 | allantoin / lidocaine / petrolatum Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1540662 | allantoin / lidocaine / petrolatum | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1540663 | allantoin 2 % / lidocaine 4 % / petrolatum 30 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1540663 | allantoin 2 % / lidocaine 4 % / petrolatum 30 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1540663 | allantoin 2 % / lidocaine 4 % / petrolatum 30 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1540664 | Vexa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1540665 | allantoin 0.02 MG/MG / lidocaine 0.04 MG/MG / petrolatum 0.3 MG/MG [Vexa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540667 | Vexa Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540669 | Vexa-D 2 % / 4 % / 30 % Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1540669 | Vexa-D 2 % / 4 % / 30 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540669 | Vexa-D 2 % / 4 % / 30 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540676 | menthol 11 % / methyl salicylate 11 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1540676 | menthol 11 % / methyl salicylate 11 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540676 | menthol 11 % / methyl salicylate 11 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154077 | Coronary vasodilator | Designated preferred name (PT) | NO | |
| RxCUI: 154077 | Coronary vasodilator | Full form of descriptor (FN) | NO | |
| RxCUI: 1540822 | Brucella abortus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540823 | escargot shell, cooked | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540824 | tedizolid phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1540824 | tedizolid phosphate | Designated preferred name (PT) | YES | |
| RxCUI: 1540824 | tedizolid phosphate | Full form of descriptor (FN) | YES | |
| RxCUI: 1540825 | tedizolid | Full form of descriptor (FN) | YES | |
| RxCUI: 1540825 | tedizolid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1540825 | tedizolid | Designated preferred name (PT) | YES | |
| RxCUI: 1540825 | tedizolid | Full form of descriptor (FN) | YES | |
| RxCUI: 1540825 | tedizolid | Designated preferred name (PT) | YES | |
| RxCUI: 1540826 | behenyl erucate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1540827 | Cardiospermum halicacbum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540828 | n-perfluorohexane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540828 | n-perfluorohexane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540828 | n-perfluorohexane | Designated preferred name (PT) | NO | |
| RxCUI: 1540828 | n-perfluorohexane | Full form of descriptor (FN) | NO | |
| RxCUI: 1540828 | n-perfluorohexane | Designated preferred name (PT) | NO | |
| RxCUI: 1540828 | n-perfluorohexane | Full form of descriptor (FN) | NO | |
| RxCUI: 1540829 | Fortolin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1540830 | acetaminophen 500 MG [Fortolin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540831 | acetaminophen Oral Tablet [Fortolin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1540832 | Fortolin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540833 | Fortolin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540834 | Fortolin 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1540834 | Fortolin 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540834 | Fortolin 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540834 | Fortolin 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540835 | petrolatum 0.933 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1540836 | petrolatum Rectal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1540837 | petrolatum Rectal Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1540838 | petrolatum 93.3 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1540838 | petrolatum 93.3 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540838 | petrolatum 93.3 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540839 | Hemo-Fin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1540840 | petrolatum 0.933 MG/MG [Hemo-Fin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540841 | petrolatum Rectal Ointment [Hemo-Fin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1540842 | Hemo-Fin Rectal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540843 | Hemo-Fin 93.3 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540843 | Hemo-Fin 93.3 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540843 | Hemo-Fin 93.3 % Rectal Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1540844 | ferrous fumarate 456 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1540845 | iron (as ferrous fumarate) 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1540845 | iron (as ferrous fumarate) 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1540846 | ferrous fumarate 456 MG [Ferrimin 150] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1540847 | Ferrimin (iron) 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1540847 | Ferrimin (iron) 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1540847 | Ferrimin (iron) 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1540850 | Vetropolycin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1540851 | bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG [Vetropolycin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540852 | bacitracin / neomycin / polymyxin B Ophthalmic Ointment [Vetropolycin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1540853 | Vetropolycin Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540854 | VETROPOLYCIN 400 UNT / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1540854 | VETROPOLYCIN 400 UNT / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540854 | VETROPOLYCIN 400 UNT / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540858 | tedizolid phosphate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1540859 | tedizolid Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1540859 | tedizolid Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1540859 | tedizolid Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1540860 | tedizolid Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1540861 | tedizolid Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1540862 | tedizolid phosphate 200 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1540862 | tedizolid phosphate 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1540862 | tedizolid phosphate 200 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1540862 | tedizolid phosphate 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1540863 | Sivextro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1540864 | tedizolid phosphate 200 MG [Sivextro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1540865 | tedizolid Oral Tablet [Sivextro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1540866 | Sivextro Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1540867 | Sivextro Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1540868 | Sivextro 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1540868 | Sivextro 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1540868 | Sivextro 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1540869 | Jasminum sambac flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1540870 | ethyl methicone (8 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540871 | ethyl perfluorobutyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1540872 | Eucalyptus radiata flower top oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540873 | meadowfoam seed oil fatty acids | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540874 | Centipeda minima whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540875 | perfluoroperhydrophenanthrene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540876 | polyglyceryl-4-oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1540877 | Chondrus crispus carrageenan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1540878 | octyldodecyl behenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1540879 | undecyl ethyleneglycol monoether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540880 | Cistus ladanifer resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540881 | hydrogenated jojoba oil, randomized | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1540882 | glycolide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1540884 | tedizolid Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1540884 | tedizolid Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1540884 | tedizolid Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 1540886 | tedizolid phosphate 200 MG Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 1540886 | tedizolid phosphate 200 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1540886 | tedizolid phosphate 200 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1540886 | tedizolid phosphate 200 MG Injection | Designated preferred name (PT) | YES | |
| RxCUI: 1540889 | Sivextro Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1540890 | Sivextro 200 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1540890 | Sivextro 200 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1540890 | Sivextro 200 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1540973 | benzocaine 0.035 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1540974 | benzocaine 3.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1540974 | benzocaine 3.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540974 | benzocaine 3.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540980 | Fluriso | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1540981 | isoflurane 999 MG/ML [Fluriso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1540983 | Fluriso Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1540984 | Fluriso 99.9 % Inhalation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1540984 | Fluriso 99.9 % Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1540984 | Fluriso 99.9 % Inhalation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1541083 | capsaicin 0.035 % / menthol 10 % / methyl salicylate 25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1541083 | capsaicin 0.035 % / menthol 10 % / methyl salicylate 25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1541083 | capsaicin 0.035 % / menthol 10 % / methyl salicylate 25 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1541084 | hydrocortisone 1 % / pramoxine HCl 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541084 | hydrocortisone 1 % / pramoxine HCl 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541084 | hydrocortisone 1 % / pramoxine HCl 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1541086 | allantoin 0.5 % / dimethicone 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541086 | allantoin 0.5 % / dimethicone 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541086 | allantoin 0.5 % / dimethicone 5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1541087 | Anti Bac | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1541088 | benzoyl peroxide 50 MG/ML [Anti Bac] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1541089 | benzoyl peroxide Topical Lotion [Anti Bac] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1541090 | Anti Bac Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1541091 | Anti Bac 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541091 | Anti Bac 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541091 | Anti Bac 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541091 | Anti Bac 5 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1541092 | chloroxylenol 4.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1541093 | triclosan 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1541094 | chloroxylenol 0.45 % / triclosan 0.06 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541094 | chloroxylenol 0.45 % / triclosan 0.06 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541094 | chloroxylenol 0.45 % / triclosan 0.06 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1541095 | Clodan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1541096 | clobetasol propionate 0.5 MG/ML [Clodan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1541097 | clobetasol Medicated Shampoo [Clodan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1541098 | Clodan Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1541099 | Clodan 0.05 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1541099 | Clodan 0.05 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1541099 | Clodan 0.05 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1541099 | Clodan 0.05 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1541100 | Dermalquench Clear | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1541101 | salicylic acid 0.005 MG/MG [Dermalquench Clear] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1541102 | salicylic acid Topical Gel [Dermalquench Clear] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1541103 | Dermalquench Clear Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1541104 | DermalQuench Clear 0.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541104 | DermalQuench Clear 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541104 | DermalQuench Clear 0.5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1541105 | Hydraclear | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1541106 | salicylic acid 0.005 MG/MG [Hydraclear] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1541107 | salicylic acid Topical Gel [Hydraclear] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1541108 | Hydraclear Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1541109 | HydraClear 0.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541109 | HydraClear 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541109 | HydraClear 0.5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1541111 | Vetropolycin HC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1541112 | bacitracin 0.4 UNT/MG / hydrocortisone 0.01 MG/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG [Vetropolycin HC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1541113 | bacitracin / hydrocortisone / neomycin / polymyxin B Ophthalmic Ointment [Vetropolycin HC] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1541114 | Vetropolycin HC Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1541115 | VETROPOLYCIN HC 400 UNT / 10 MG / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1541115 | VETROPOLYCIN HC 400 UNT / 10 MG / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541115 | VETROPOLYCIN HC 400 UNT / 10 MG / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541115 | VETROPOLYCIN HC 400 UNT / 10 MG / 3.5 MG / 10,000 UNT per GM Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541116 | caprylyl caprylate-caprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 154114 | Substance with elastase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 154114 | Substance with elastase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 154114 | Substance with elastase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 154114 | Substance with elastase inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154114 | Substance with elastase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1541209 | camphor 3.1 % / menthol 8 % / methyl salicylate 10 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1541209 | camphor 3.1 % / menthol 8 % / methyl salicylate 10 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541209 | camphor 3.1 % / menthol 8 % / methyl salicylate 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541210 | chlorhexidine / hydrocortisone Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1541211 | chlorhexidine / hydrocortisone Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1541212 | chlorhexidine / hydrocortisone | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1541213 | chlorhexidine gluconate 4 % / hydrocortisone 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541213 | chlorhexidine gluconate 4 % / hydrocortisone 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541213 | chlorhexidine gluconate 4 % / hydrocortisone 1 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1541215 | methotrexate 2.5 MG (12) (7.5 MG per Week) Oral Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1541215 | methotrexate 2.5 MG (12) (7.5 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541216 | Rheumatrex 2.5 MG (12) (7.5 MG per Week) Oral Tablet Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1541216 | Rheumatrex 2.5 MG (12) (7.5 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541216 | Rheumatrex 2.5 MG (12) (7.5 MG per Week) Oral Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541217 | methotrexate 2.5 MG (16) (10 MG per Week) Oral Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1541217 | methotrexate 2.5 MG (16) (10 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541218 | Rheumatrex 2.5 MG (16) (10 MG per Week) Oral Tablet Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1541218 | Rheumatrex 2.5 MG (16) (10 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541218 | Rheumatrex 2.5 MG (16) (10 MG per Week) Oral Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541220 | methotrexate 2.5 MG (20) (12.5 MG per Week) Oral Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1541220 | methotrexate 2.5 MG (20) (12.5 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541221 | Rheumatrex 2.5 MG (20) (12.5 MG per Week) Oral Tablet Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1541221 | Rheumatrex 2.5 MG (20) (12.5 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541221 | Rheumatrex 2.5 MG (20) (12.5 MG per Week) Oral Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541222 | methotrexate 2.5 MG (24) (15 MG per Week) Oral Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1541222 | methotrexate 2.5 MG (24) (15 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541224 | Rheumatrex 2.5 MG (24) (15 MG per Week) Oral Tablet Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1541224 | Rheumatrex 2.5 MG (24) (15 MG per Week) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541224 | Rheumatrex 2.5 MG (24) (15 MG per Week) Oral Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541225 | methotrexate 2.5 MG Oral Tablet (28) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1541225 | methotrexate 2.5 MG Oral Tablet (28) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541226 | Rheumatrex Dose Pack 28, 4 Week Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1541226 | Rheumatrex Dose Pack 28, 4 Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541226 | Rheumatrex Dose Pack 28, 4 Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541227 | methotrexate 2.5 MG Oral Tablet (32) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1541227 | methotrexate 2.5 MG Oral Tablet (32) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541228 | Rheumatrex Dose Pack 32, 4 Week Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1541228 | Rheumatrex Dose Pack 32, 4 Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541228 | Rheumatrex Dose Pack 32, 4 Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541229 | zinc oxide 5 % / dimethicone 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541229 | zinc oxide 5 % / dimethicone 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1541229 | zinc oxide 5 % / dimethicone 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541229 | zinc oxide 5 % / dimethicone 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541233 | Achromycin V 500 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541233 | Achromycin V 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541233 | Achromycin V 500 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1541234 | ammonium acryloyldimethyltaurate - beheneth-25 methacrylate crosspolymer (52000 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541235 | biosaccharide gum-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541236 | C12-17 alkane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541237 | Eupolyphaga sinensis preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541238 | ferrous cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1541239 | Fragaria vesca whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 154124 | Ether hydrolase | Designated preferred name (PT) | NO | |
| RxCUI: 154124 | Ether hydrolase | Full form of descriptor (FN) | NO | |
| RxCUI: 1541240 | Geum urbanum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541241 | Petasites hybridus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541242 | Quercus robur whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541243 | Rheum tanguticum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541244 | Sphagnum squarrosum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1541245 | dipotassium glucose-6-phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1541246 | Glucose-6-phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1541246 | Glucose-6-phosphate | Designated preferred name (PT) | YES | |
| RxCUI: 1541246 | Glucose-6-phosphate | Full form of descriptor (FN) | YES | |
| RxCUI: 1541247 | ethyl perfluoroisobutyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1541248 | PEG-PPG-25-25 dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541249 | polignate sodium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541250 | Acnefree BP | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1541251 | benzoyl peroxide 100 MG/ML [Acnefree BP] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1541252 | benzoyl peroxide Topical Lotion [Acnefree BP] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1541253 | Acnefree BP Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1541254 | AcneFree BP 10 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541254 | AcneFree BP 10 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541254 | AcneFree BP 10 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1541259 | benzoyl peroxide 3.7 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541259 | benzoyl peroxide 3.7 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541259 | benzoyl peroxide 3.7 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1541260 | benzoyl peroxide 37 MG/ML [Acnefree BP] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1541261 | AcneFree BP 3.7 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541261 | AcneFree BP 3.7 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541261 | AcneFree BP 3.7 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1541263 | Acnefree SA | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1541264 | salicylic acid 20 MG/ML [Acnefree SA] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1541265 | salicylic acid Medicated Pad [Acnefree SA] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1541266 | Acnefree SA Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1541267 | Acnefree SA Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1541268 | Acnefree SA 2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541268 | Acnefree SA 2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541268 | Acnefree SA 2 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 154134 | Flavonoid | Designated preferred name (PT) | NO | |
| RxCUI: 154134 | Flavonoid | Full form of descriptor (FN) | NO | |
| RxCUI: 154134 | Flavonoid | Designated preferred name (PT) | NO | |
| RxCUI: 154134 | Flavonoid | Full form of descriptor (FN) | NO | |
| RxCUI: 1541465 | dalbavancin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1541465 | dalbavancin hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 1541465 | dalbavancin hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 1541591 | menthol 0.08 MG/MG [Stopain] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1541592 | Stopain COLD 8 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1541592 | Stopain COLD 8 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541592 | Stopain COLD 8 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541592 | Stopain COLD 8 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541593 | potassium chloride 8 MEQ [K-Tab] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1541594 | K-Tab 8 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1541594 | K-Tab 8 MEQ Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1541594 | K-Tab 8 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1541594 | K-Tab 8 MEQ Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1541594 | K-Tab 8 MEQ Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1541597 | polyvinyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1541608 | menthol 6 % / methyl salicylate 10 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1541608 | menthol 6 % / methyl salicylate 10 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541608 | menthol 6 % / methyl salicylate 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541609 | Dexedrine 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1541609 | Dexedrine 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1541609 | Dexedrine 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1541610 | salicylic acid 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1541610 | salicylic acid 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541610 | salicylic acid 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541630 | codeine phosphate 10 MG / brompheniramine maleate 4 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1541630 | codeine phosphate 10 MG / brompheniramine maleate 4 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1541630 | codeine phosphate 10 MG / brompheniramine maleate 4 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1541636 | colloidal oatmeal 0.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1541641 | camphor 6 % / menthol 1.25 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541641 | camphor 6 % / menthol 1.25 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541641 | camphor 6 % / menthol 1.25 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1541696 | salicylic acid 2 % Topical Gel (30 ML) / salicylic acid 2 % Medicated Liquid Soap (150 ML) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1541696 | salicylic acid 2 % Topical Gel (30 ML) / salicylic acid 2 % Medicated Liquid Soap (150 ML) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541697 | Take Control | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1541698 | salicylic acid 20 MG/ML [Take Control] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1541699 | salicylic acid Medicated Liquid Soap [Take Control] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1541700 | Take Control Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1541701 | Take Control 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1541701 | Take Control 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541701 | Take Control 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541702 | Let Me Clarify | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1541703 | salicylic acid 0.02 MG/MG [Let Me Clarify] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1541704 | salicylic acid Topical Gel [Let Me Clarify] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1541705 | Let Me Clarify Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1541706 | Let Me Clarify 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541706 | Let Me Clarify 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541706 | Let Me Clarify 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1541707 | Erase It Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1541707 | Erase It Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541707 | Erase It Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541708 | Arctium lappa fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541709 | Mallotus japonicus flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541710 | Rubus idaeus fruit volatile oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1541711 | Santalum album seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541712 | Zingiber cassumunar root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541714 | Cimicifuga simplex root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541715 | Citrus aurantiifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541716 | Coriandrum sativum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541717 | Cucurbita pepo whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1541718 | Eremocitrus glauca fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1541719 | Jasminum officinale whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1541720 | Laurus nobilis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541721 | Sesamum indicum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541722 | Lawsonia inermis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541723 | Pinus densiflora leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541724 | Triticum polonicum seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541725 | Gardenia resinifera resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541726 | Cananga odorata flower wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541727 | Brassica oleracea var. italica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1541728 | Eruca vesicaria subsp. sativa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541729 | mammal bone, fossilized | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541730 | Cinnamomum camphora resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541731 | Eucalyptus gum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1541732 | Coix lacryma-jobi var. ma-yuen seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541733 | hydroxyacetophenone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1541733 | hydroxyacetophenone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1541734 | biosaccharide gum-4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541735 | black catechu extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541736 | quaternium-82 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541737 | capramidopropyl betaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541738 | steareth-20 methacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541739 | steareth-7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541740 | Taraxacum mongolicum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541740 | Taraxacum mongolicum whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541741 | hydroxypropyl bisstearamide monoethanolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541742 | sodium hinokitiol | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1541743 | trehalose isostearate esters | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541744 | cholesteryl isostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541745 | dipentaerythrityl hexastearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541746 | methyl ricinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541747 | polyglyceryl-10 hexaoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541749 | polyglycerol polyricinoleic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1541750 | glyceran polyricinoleic acid ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541811 | Bencocaine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1541812 | benzocaine 0.2 MG/MG [Bencocaine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1541813 | benzocaine Oral Gel [Bencocaine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1541814 | Bencocaine Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1541815 | Bencocaine Oral Gel Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1541816 | BencoCaine 20 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1541816 | BencoCaine 20 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541816 | BencoCaine 20 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1541816 | BencoCaine 20 % Oral Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1541881 | Angelica gigas root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541882 | Artemisia vulgaris whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1541883 | Cnidium officinale root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541884 | Gardenia jasminoides whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1541885 | PPG-26 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541886 | PEG-8 propylheptyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1541889 | sunitinib 37.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1541889 | sunitinib 37.5 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1541890 | SUNItinib malate 37.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1541890 | SUNItinib malate 37.5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1541890 | SUNItinib malate 37.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1541890 | SUNItinib malate 37.5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1541890 | SUNItinib malate 37.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1541927 | sunitinib 37.5 MG [Sutent] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1541927 | sunitinib 37.5 MG [Sutent] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1541928 | Sutent 37.5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1541928 | Sutent 37.5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1541928 | Sutent 37.5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1541928 | Sutent 37.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1541929 | Liquimat | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1541930 | sulfur 50 MG/ML [Liquimat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1541931 | sulfur Topical Lotion [Liquimat] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1541932 | Liquimat Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1541933 | Liquimat 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1541933 | Liquimat 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1541933 | Liquimat 5 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1542375 | pentaerythrityl tetrabehenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1542377 | sulfacetamide sodium 9.8 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542377 | sulfacetamide sodium 9.8 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1542378 | sulfacetamide sodium 98 MG/ML [Ovace] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1542379 | sulfacetamide Topical Lotion [Ovace] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1542380 | Ovace Plus 9.8 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542380 | Ovace Plus 9.8 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542380 | Ovace Plus 9.8 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542380 | Ovace Plus 9.8 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1542381 | Vazculep | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1542382 | phenylephrine hydrochloride 10 MG/ML [Vazculep] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1542383 | phenylephrine Injectable Solution [Vazculep] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1542384 | Vazculep Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1542385 | Vazculep 10 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1542385 | Vazculep 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542385 | Vazculep 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542385 | Vazculep 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542385 | Vazculep 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542386 | buprenorphine 2.1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1542387 | naloxone 0.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1542388 | buprenorphine / naloxone Buccal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1542389 | buprenorphine / naloxone Buccal Film | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1542390 | buprenorphine 2.1 MG / naloxone 0.3 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542390 | buprenorphine 2.1 MG / naloxone 0.3 MG Buccal Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1542391 | Bunavail | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1542392 | buprenorphine 2.1 MG / naloxone 0.3 MG [Bunavail] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1542393 | buprenorphine / naloxone Buccal Film [Bunavail] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1542394 | Bunavail Buccal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1542395 | Bunavail Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1542396 | Bunavail 2.1 / 0.3 Buccal Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542396 | Bunavail 2.1 / 0.3 Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542396 | Bunavail 2.1 / 0.3 Buccal Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1542397 | (APAP 500 MG / dextromethorphan HBr 20 MG / doxylamine succinate 12.5 MG / phenylephrine HCl 10 MG) per 240 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542397 | (APAP 500 MG / dextromethorphan HBr 20 MG / doxylamine succinate 12.5 MG / phenylephrine HCl 10 MG) per 240 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1542397 | (APAP 500 MG / dextromethorphan HBr 20 MG / doxylamine succinate 12.5 MG / phenylephrine HCl 10 MG) per 240 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542452 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542452 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1542452 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542452 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542452 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1542452 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1542452 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1542454 | calcium chlorate dihydrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1542518 | buprenorphine 6.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1542796 | hydrocortisone acetate 2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1542796 | hydrocortisone acetate 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542797 | hydrocortisone acetate 0.02 MG/MG [CortAlo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1542798 | CortAlo 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542798 | CortAlo 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542798 | CortAlo 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542798 | CortAlo 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1542800 | benzocaine Oral Gel [Zilactin B] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1542801 | Zilactin B Oral Gel Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1542802 | Zilactin B Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1542803 | zilactin-B 10 % Oral Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1542803 | zilactin-B 10 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542803 | zilactin-B 10 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542803 | zilactin-B 10 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542804 | hydrocortisone acetate 0.5 % / neomycin 0.35 % / polymyxin B 10,000 UNT/ML Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542804 | hydrocortisone acetate 0.5 % / neomycin 0.35 % / polymyxin B 10,000 UNT/ML Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542804 | hydrocortisone acetate 0.5 % / neomycin 0.35 % / polymyxin B 10,000 UNT/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1542805 | hydrocortisone acetate 5 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML [Cortisporin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1542806 | CORTISPORIN 0.5 % / 0.35 % / 10,000 UNT per GM Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542806 | CORTISPORIN 0.5 % / 0.35 % / 10,000 UNT per GM Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542806 | CORTISPORIN 0.5 % / 0.35 % / 10,000 UNT per GM Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542806 | CORTISPORIN 0.5 % / 0.35 % / 10,000 UNT per GM Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1542812 | tetracycline hydrochloride 0.03 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1542813 | tetracycline HCl 3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542813 | tetracycline HCl 3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542813 | tetracycline HCl 3 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1542814 | tetracycline hydrochloride 0.03 MG/MG [Diabecline] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1542815 | Diabecline 3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542815 | Diabecline 3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542815 | Diabecline 3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542815 | Diabecline 3 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1542816 | camphor 11 % / menthol 7.6 % / methyl salicylate 13 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1542816 | camphor 11 % / menthol 7.6 % / methyl salicylate 13 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542817 | camphor 0.11 MG/MG / menthol 0.076 MG/MG / methyl salicylate 0.13 MG/MG [Katinko] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1542818 | Katinko (camphor 11 % / menthol 7.6 % / methyl salicylate 13 % ) Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1542818 | Katinko (camphor 11 % / menthol 7.6 % / methyl salicylate 13 % ) Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542818 | Katinko (camphor 11 % / menthol 7.6 % / methyl salicylate 13 % ) Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542819 | histamine dihydrochloride 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1542820 | histamine dihydrochloride 0.05 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542820 | histamine dihydrochloride 0.05 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542820 | histamine dihydrochloride 0.05 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1542821 | Australian Dream | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1542822 | histamine dihydrochloride 0.5 MG/ML [Australian Dream] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1542823 | histamine Topical Cream [Australian Dream] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1542824 | Australian Dream Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1542825 | Australian Dream 0.05 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542825 | Australian Dream 0.05 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542825 | Australian Dream 0.05 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1542834 | tetracycline hydrochloride 0.03 MG/MG [Achromycin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1542835 | Achromycin 3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542835 | Achromycin 3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542835 | Achromycin 3 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1542857 | salicylic acid Medicated Liquid Soap [No Zit Sherlock] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1542858 | No Zit Sherlock Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1542859 | no 'zit' sherlock purifying 2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542859 | no 'zit' sherlock purifying 2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542859 | no 'zit' sherlock purifying 2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1542893 | Olioactiv | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1542894 | cetylpyridinium chloride 0.5 MG/ML [Olioactiv] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1542895 | cetylpyridinium Mouthwash [Olioactiv] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1542896 | Olioactiv Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1542897 | Olioactiv Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1542898 | Olioactiv Mouthwash Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1542899 | olio activ 0.05 % Mouthwash | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1542899 | olio activ 0.05 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542899 | olio activ 0.05 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542900 | cauloside D | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1542901 | propylene glycol 1-(2-methylbutyrate) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1542917 | sodium chloride 2300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1542918 | sodium bicarbonate / sodium chloride Powder for Nasal Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1542919 | sodium bicarbonate 700 MG / sodium chloride 2300 MG Powder for Nasal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542919 | sodium bicarbonate 700 MG / sodium chloride 2300 MG Powder for Nasal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542919 | sodium bicarbonate 700 MG / sodium chloride 2300 MG Powder for Nasal Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1542920 | hydrocortisone acetate 0.5 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1542920 | hydrocortisone acetate 0.5 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542920 | hydrocortisone acetate 0.5 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542920 | hydrocortisone acetate 0.5 % Ophthalmic Ointment | Designated preferred name (PT) | NO | |
| RxCUI: 1542920 | hydrocortisone acetate 0.5 % Ophthalmic Ointment | Full form of descriptor (FN) | NO | |
| RxCUI: 1542921 | hydrocortisone acetate 1 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1542921 | hydrocortisone acetate 1 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542921 | hydrocortisone acetate 1 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542921 | hydrocortisone acetate 1 % Ophthalmic Ointment | Designated preferred name (PT) | NO | |
| RxCUI: 1542921 | hydrocortisone acetate 1 % Ophthalmic Ointment | Full form of descriptor (FN) | NO | |
| RxCUI: 1542922 | hydrocortisone acetate 2.5 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1542922 | hydrocortisone acetate 2.5 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542922 | hydrocortisone acetate 2.5 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542922 | hydrocortisone acetate 2.5 % Ophthalmic Ointment | Designated preferred name (PT) | NO | |
| RxCUI: 1542922 | hydrocortisone acetate 2.5 % Ophthalmic Ointment | Full form of descriptor (FN) | NO | |
| RxCUI: 1542924 | hydrocortisone acetate 0.015 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1542925 | hydrocortisone acetate 1.5 % Ophthalmic Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1542925 | hydrocortisone acetate 1.5 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542925 | hydrocortisone acetate 1.5 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542927 | miconazole Vaginal Ointment [Femmesil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1542928 | Femmesil Vaginal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1542929 | Femmesil 2 % Vaginal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542929 | Femmesil 2 % Vaginal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542929 | Femmesil 2 % Vaginal Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1542941 | vancomycin (as vancomycin hydrochloride) 25 MG/ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542941 | vancomycin (as vancomycin hydrochloride) 25 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1542942 | vancomycin (as vancomycin hydrochloride) 50 MG/ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542942 | vancomycin (as vancomycin hydrochloride) 50 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1542976 | Verdrocet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1542977 | acetaminophen 325 MG / hydrocodone bitartrate 2.5 MG [Verdrocet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1542977 | acetaminophen 325 MG / hydrocodone bitartrate 2.5 MG [Verdrocet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1542978 | acetaminophen / hydrocodone Oral Tablet [Verdrocet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1542978 | acetaminophen / hydrocodone Oral Tablet [Verdrocet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1542979 | Verdrocet Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 154298 | Oxidoreductase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 154298 | Oxidoreductase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 1542980 | Verdrocet Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1542981 | Verdrocet 2.5 MG / 325 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1542981 | Verdrocet 2.5 MG / 325 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1542981 | Verdrocet 2.5 MG / 325 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542981 | Verdrocet 2.5 MG / 325 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1542981 | Verdrocet 2.5 MG / 325 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542983 | Xylon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1542984 | hydrocodone bitartrate 10 MG / ibuprofen 200 MG [Xylon] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1542984 | hydrocodone bitartrate 10 MG / ibuprofen 200 MG [Xylon] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1542985 | hydrocodone / ibuprofen Oral Tablet [Xylon] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1542985 | hydrocodone / ibuprofen Oral Tablet [Xylon] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1542986 | Xylon Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1542987 | Xylon Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1542988 | Xylon 10, 10 MG / 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1542988 | Xylon 10, 10 MG / 200 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1542988 | Xylon 10, 10 MG / 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542988 | Xylon 10, 10 MG / 200 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1542988 | Xylon 10, 10 MG / 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542990 | Neo-Synalar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1542991 | fluocinolone acetonide 0.25 MG/ML / neomycin sulfate 5 MG/ML [Neo-Synalar] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1542992 | fluocinolone / neomycin Topical Cream [Neo-Synalar] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1542993 | Neo-Synalar Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1542994 | NEO-SYNALAR 0.5 % (0.35 % ) / 0.025 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1542994 | NEO-SYNALAR 0.5 % (0.35 % ) / 0.025 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542994 | NEO-SYNALAR 0.5 % (0.35 % ) / 0.025 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542995 | lidocaine 0.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1542995 | lidocaine 0.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1542995 | lidocaine 0.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1542996 | buprenorphine 0.0075 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1542997 | buprenorphine 7.5 MCG/HR 7 Day Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1542997 | buprenorphine 7.5 MCG/HR 7 Day Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542997 | buprenorphine 7.5 MCG/HR 7 Day Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542997 | buprenorphine 7.5 MCG/HR 7 Day Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542998 | buprenorphine 0.0075 MG/HR [BuTrans] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1542999 | Butrans 7.5 MCG/HR 7 Day Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1542999 | Butrans 7.5 MCG/HR 7 Day Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542999 | Butrans 7.5 MCG/HR 7 Day Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1542999 | Butrans 7.5 MCG/HR 7 Day Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1542999 | Butrans 7.5 MCG/HR 7 Day Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543000 | buprenorphine 0.0075 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1543001 | buprenorphine 0.0075 MG/HR Transdermal System [BuTrans] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1543001 | buprenorphine 0.0075 MG/HR Transdermal System [BuTrans] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543001 | buprenorphine 0.0075 MG/HR Transdermal System [BuTrans] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543002 | amylase 15125 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1543003 | protease 14375 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1543004 | lipase 4000 UNT / amylase 15,125 UNT / protease 14,375 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543004 | lipase 4000 UNT / amylase 15,125 UNT / protease 14,375 UNT Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1543004 | lipase 4000 UNT / amylase 15,125 UNT / protease 14,375 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543004 | lipase 4000 UNT / amylase 15,125 UNT / protease 14,375 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543005 | amylase 15125 UNT / lipase 4000 UNT / protease 14375 UNT [Pertzye] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1543006 | Pertzye 4000 UNT / 15,125 UNT / 14,375 UNT Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1543006 | Pertzye 4000 UNT / 15,125 UNT / 14,375 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543006 | Pertzye 4000 UNT / 15,125 UNT / 14,375 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543006 | Pertzye 4000 UNT / 15,125 UNT / 14,375 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543069 | lidocaine 5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1543069 | lidocaine 5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543069 | lidocaine 5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543070 | acetaminophen / caffeine Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1543071 | acetaminophen / caffeine Oral Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1543072 | acetaminophen 650 MG / caffeine 50 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543072 | acetaminophen 650 MG / caffeine 50 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1543072 | acetaminophen 650 MG / caffeine 50 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543073 | tripelennamine hydrochloride 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1543074 | tripelennamine HCl 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543074 | tripelennamine HCl 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543074 | tripelennamine HCl 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1543077 | Euphorbia hirta flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1543078 | methyl undecylenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1543079 | ethyl 10-undecenoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1543081 | certeareth-100 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1543082 | bergamot orange extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1543089 | Eloctate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1543092 | Eloctate Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1543095 | (1-743)-(1638-2332)-blood-coagulation factor VIII (synthetic human) fusion protein with immunoglobulin G1 (synthetic human fc domain fragment), (1444-6'),(1447-9')-bis(disulfide) with immunoglobulin G1 (synthetic human fc domain fragment) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543095 | (1-743)-(1638-2332)-blood-coagulation factor VIII (synthetic human) fusion protein with immunoglobulin G1 (synthetic human fc domain fragment), (1444-6'),(1447-9')-bis(disulfide) with immunoglobulin G1 (synthetic human fc domain fragment) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1543095 | (1-743)-(1638-2332)-blood-coagulation factor VIII (synthetic human) fusion protein with immunoglobulin G1 (synthetic human fc domain fragment), (1444-6'),(1447-9')-bis(disulfide) with immunoglobulin G1 (synthetic human fc domain fragment) | Designated preferred name (PT) | YES | |
| RxCUI: 1543095 | (1-743)-(1638-2332)-blood-coagulation factor VIII (synthetic human) fusion protein with immunoglobulin G1 (synthetic human fc domain fragment), (1444-6'),(1447-9')-bis(disulfide) with immunoglobulin G1 (synthetic human fc domain fragment) | Full form of descriptor (FN) | YES | |
| RxCUI: 1543095 | (1-743)-(1638-2332)-blood-coagulation factor VIII (synthetic human) fusion protein with immunoglobulin G1 (synthetic human fc domain fragment), (1444-6'),(1447-9')-bis(disulfide) with immunoglobulin G1 (synthetic human fc domain fragment) | Designated preferred name (PT) | YES | |
| RxCUI: 1543095 | (1-743)-(1638-2332)-blood-coagulation factor VIII (synthetic human) fusion protein with immunoglobulin G1 (synthetic human fc domain fragment), (1444-6'),(1447-9')-bis(disulfide) with immunoglobulin G1 (synthetic human fc domain fragment) | Full form of descriptor (FN) | YES | |
| RxCUI: 1543097 | efmoroctocog alfa Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1543097 | efmoroctocog alfa Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 1543097 | efmoroctocog alfa Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 154313 | Peptide hormone | Designated preferred name (PT) | NO | |
| RxCUI: 154313 | Peptide hormone | Full form of descriptor (FN) | NO | |
| RxCUI: 1543157 | tetracaine hydrochloride 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1543158 | tetracaine HCl 2 % Topical Cream | Full form of descriptor (FN) | YES | |
| RxCUI: 1543158 | tetracaine HCl 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543158 | tetracaine HCl 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543158 | tetracaine HCl 2 % Topical Cream | Designated preferred name (PT) | YES | |
| RxCUI: 1543158 | tetracaine HCl 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1543159 | tetracaine hydrochloride 20 MG/ML [Viractin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1543160 | Viractin 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1543160 | Viractin 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543160 | Viractin 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543160 | Viractin 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543161 | tetracaine hydrochloride 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1543162 | tetracaine HCl 2 % Topical Gel | Full form of descriptor (FN) | NO | |
| RxCUI: 1543162 | tetracaine HCl 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543162 | tetracaine HCl 2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1543162 | tetracaine HCl 2 % Topical Gel | Designated preferred name (PT) | NO | |
| RxCUI: 1543163 | tetracaine hydrochloride 0.02 MG/MG [Viractin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1543164 | Viractin 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1543164 | Viractin 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543164 | Viractin 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543165 | carbamide peroxide Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1543166 | carbamide peroxide Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1543167 | carbamide peroxide 11 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1543167 | carbamide peroxide 11 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543167 | carbamide peroxide 11 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543168 | Broda Acne Spa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1543169 | salicylic acid 0.02 MG/MG [Broda Acne Spa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1543170 | salicylic acid Topical Gel [Broda Acne Spa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1543171 | Broda Acne Spa Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1543172 | Broda Acne Spa 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543172 | Broda Acne Spa 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543172 | Broda Acne Spa 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543172 | Broda Acne Spa 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1543173 | tavaborole | Full form of descriptor (FN) | YES | |
| RxCUI: 1543173 | tavaborole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1543173 | tavaborole | Designated preferred name (PT) | YES | |
| RxCUI: 1543173 | tavaborole | Full form of descriptor (FN) | YES | |
| RxCUI: 1543173 | tavaborole | Designated preferred name (PT) | YES | |
| RxCUI: 1543174 | tavaborole 43.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1543175 | tavaborole Topical Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1543175 | tavaborole Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1543175 | tavaborole Topical Product | Designated preferred name (PT) | YES | |
| RxCUI: 1543176 | tavaborole Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1543177 | tavaborole 5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1543177 | tavaborole 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543177 | tavaborole 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543178 | Kerydin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1543179 | tavaborole 43.5 MG/ML [Kerydin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1543180 | tavaborole Topical Solution [Kerydin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1543181 | Kerydin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1543182 | KERYDIN 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543182 | KERYDIN 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543182 | KERYDIN 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543182 | KERYDIN 5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1543185 | sucrose octastearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1543187 | testosterone 5.5 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1543188 | testosterone Nasal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1543189 | testosterone Nasal Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1543190 | testosterone 5.5 MG/ACTUAT Nasal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1543191 | Natesto | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1543192 | testosterone 5.5 MG/ACTUAT [Natesto] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1543193 | testosterone Nasal Gel [Natesto] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1543194 | Natesto Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1543195 | testosterone 5.5 MG/ACTUAT Nasal Gel [Natesto] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543195 | testosterone 5.5 MG/ACTUAT Nasal Gel [Natesto] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1543196 | camphor 11 % / menthol 7.6 % / methyl salicylate 13.5 % Topical Stick | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1543196 | camphor 11 % / menthol 7.6 % / methyl salicylate 13.5 % Topical Stick | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543196 | camphor 11 % / menthol 7.6 % / methyl salicylate 13.5 % Topical Stick | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543197 | camphor 0.11 MG/MG / menthol 0.076 MG/MG / methyl salicylate 0.135 MG/MG [Katinko] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1543198 | Katinko 11 % / 7.6 % / 13.5 % Topical Stick | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1543198 | Katinko 11 % / 7.6 % / 13.5 % Topical Stick | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543198 | Katinko 11 % / 7.6 % / 13.5 % Topical Stick | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543200 | insulin, regular, human Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1543202 | regular insulin, human 4 UNT Inhalation Powder Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1543202 | regular insulin, human 4 UNT Inhalation Powder Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543202 | regular insulin, human 4 UNT Inhalation Powder Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543203 | Afrezza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1543206 | Afrezza Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1543207 | afrezza 4 UNT Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543207 | afrezza 4 UNT Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543207 | afrezza 4 UNT Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1543208 | testosterone 10 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1543209 | testosterone 10 MG/ACTUAT Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1543210 | testosterone 10 MG/ACTUAT [Fortesta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1543211 | testosterone 10 MG/ACTUAT Topical Gel [Fortesta] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543211 | testosterone 10 MG/ACTUAT Topical Gel [Fortesta] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1543217 | testosterone 20.25 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1543218 | testosterone 20.25 MG/ACTUAT Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1543219 | testosterone 20.25 MG/ACTUAT [Androgel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1543220 | testosterone 20.25 MG/ACTUAT Topical Gel [Androgel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543220 | testosterone 20.25 MG/ACTUAT Topical Gel [Androgel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 154325 | Phenylalkylamine | Designated preferred name (PT) | NO | |
| RxCUI: 154325 | Phenylalkylamine | Full form of descriptor (FN) | NO | |
| RxCUI: 1543293 | Asplenium scolopendrium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1543294 | Rosa x damascena whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1543294 | Rosa x damascena whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543308 | sulfacetamide sodium 9.8 % / sulfur 4.8 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543308 | sulfacetamide sodium 9.8 % / sulfur 4.8 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543308 | sulfacetamide sodium 9.8 % / sulfur 4.8 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1543309 | Alevazol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1543310 | clotrimazole 0.01 MG/MG [Alevazol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1543311 | clotrimazole Topical Ointment [Alevazol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1543312 | Alevazol Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1543313 | Alevazol 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543313 | Alevazol 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543313 | Alevazol 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543313 | Alevazol 1 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1543390 | benzoyl peroxide 4.4 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543390 | benzoyl peroxide 4.4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543390 | benzoyl peroxide 4.4 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1543391 | benzoyl peroxide 44 MG/ML [Benoxyl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1543392 | benzoyl peroxide Medicated Liquid Soap [Benoxyl] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1543393 | Benoxyl Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1543394 | Benoxyl-CR 4.4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543394 | Benoxyl-CR 4.4 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543394 | Benoxyl-CR 4.4 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1543398 | Xylamed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1543399 | xylazine 100 MG/ML [Xylamed] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1543400 | xylazine Injectable Solution [Xylamed] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1543401 | Xylamed Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1543402 | xylazine 100 MG/ML Injectable Solution [Xylamed] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543402 | xylazine 100 MG/ML Injectable Solution [Xylamed] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543402 | xylazine 100 MG/ML Injectable Solution [Xylamed] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1543411 | Fritillaria delavayi bulb extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1543414 | dihydroxyaluminum aminoacetate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1543415 | PEG-11 avocado glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1543422 | neomycin 0.35 % / fluocinolone acetonide 0.025 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543422 | neomycin 0.35 % / fluocinolone acetonide 0.025 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1543422 | neomycin 0.35 % / fluocinolone acetonide 0.025 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543429 | benzalkonium / benzocaine / menthol Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1543430 | benzalkonium / benzocaine / menthol Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1543431 | benzalkonium / benzocaine / menthol Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1543432 | benzocaine 20 % / menthol 0.5 % / benzalkonium chloride 0.1 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1543432 | benzocaine 20 % / menthol 0.5 % / benzalkonium chloride 0.1 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543432 | benzocaine 20 % / menthol 0.5 % / benzalkonium chloride 0.1 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543455 | methoxy PEG PPG-7-3 aminopropyl dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1543458 | ketorolac / phenylephrine Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1543459 | ketorolac / phenylephrine Ophthalmic Irrigation Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1543461 | ketorolac / phenylephrine Ophthalmic Irrigation Solution [Omidria] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1543462 | Omidria Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1543543 | belinostat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1543543 | belinostat | Designated preferred name (PT) | YES | |
| RxCUI: 1543543 | belinostat | Full form of descriptor (FN) | YES | |
| RxCUI: 1543543 | belinostat | Designated preferred name (PT) | YES | |
| RxCUI: 1543543 | belinostat | Full form of descriptor (FN) | YES | |
| RxCUI: 1543545 | belinostat Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1543545 | belinostat Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 1543545 | belinostat Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1543547 | belinostat 500 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543547 | belinostat 500 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1543547 | belinostat 500 MG Injection | Designated preferred name (PT) | YES | |
| RxCUI: 1543547 | belinostat 500 MG Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 1543548 | Beleodaq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1543551 | Beleodaq Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1543552 | Beleodaq 500 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543552 | Beleodaq 500 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543552 | Beleodaq 500 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1543553 | Nikki 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1543553 | Nikki 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543553 | Nikki 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543562 | Amlodipine mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543562 | Amlodipine mesilate | Full form of descriptor (FN) | NO | |
| RxCUI: 1543562 | Amlodipine mesilate | Designated preferred name (PT) | NO | |
| RxCUI: 1543563 | Fungus MD | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1543564 | tolnaftate 10 MG/ML [Fungus MD] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1543565 | tolnaftate Topical Solution [Fungus MD] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1543566 | Fungus MD Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1543567 | Fungus MD 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543567 | Fungus MD 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543567 | Fungus MD 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543567 | Fungus MD 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 154363 | Product containing pyrethroid (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 154363 | Product containing pyrethroid (product) | Designated preferred name (PT) | NO | |
| RxCUI: 154363 | Product containing pyrethroid (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 154363 | Product containing pyrethroid (product) | Designated preferred name (PT) | NO | |
| RxCUI: 1543704 | dimethicone 1.1 % / zinc oxide 40 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1543704 | dimethicone 1.1 % / zinc oxide 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543704 | dimethicone 1.1 % / zinc oxide 40 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543704 | dimethicone 1.1 % / zinc oxide 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543705 | Vanicream Diaper Rash | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1543706 | dimethicone 0.011 MG/MG / zinc oxide 0.4 MG/MG [Vanicream Diaper Rash] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1543707 | dimethicone / zinc oxide Topical Ointment [Vanicream Diaper Rash] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1543708 | Vanicream Diaper Rash Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1543709 | Vanicream Diaper Rash 1.1 % / 40 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1543709 | Vanicream Diaper Rash 1.1 % / 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543709 | Vanicream Diaper Rash 1.1 % / 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543709 | Vanicream Diaper Rash 1.1 % / 40 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543710 | mineral oil 0.2 MG/MG / petrolatum 0.8 MG/MG [Tears Again Ointment] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1543711 | Tears Again Ointment 20 % / 80 % Ophthalmic Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1543711 | Tears Again Ointment 20 % / 80 % Ophthalmic Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543711 | Tears Again Ointment 20 % / 80 % Ophthalmic Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543712 | lidocaine HCl 1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543712 | lidocaine HCl 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543712 | lidocaine HCl 1 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1543713 | RadiaGuard | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1543714 | lidocaine hydrochloride 10 MG/ML [RadiaGuard] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1543715 | lidocaine Topical Lotion [RadiaGuard] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1543716 | RadiaGuard Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1543717 | RadiaGuard 1 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1543717 | RadiaGuard 1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543717 | RadiaGuard 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543717 | RadiaGuard 1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543722 | amylase 450 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1543724 | lipase 30 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1543725 | amylase / Bacillus coagulans / lipase / protease Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1543726 | amylase / Bacillus coagulans / lipase / protease Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1543727 | amylase / Bacillus coagulans / lipase / protease Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1543728 | amylase / Bacillus coagulans / lipase / protease | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1543729 | lipase 30,000 UNT / amylase 450 UNT / Bacillus coagulans 1 Billion UNT / protease 450 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1543729 | lipase 30,000 UNT / amylase 450 UNT / Bacillus coagulans 1 Billion UNT / protease 450 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543729 | lipase 30,000 UNT / amylase 450 UNT / Bacillus coagulans 1 Billion UNT / protease 450 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543729 | lipase 30,000 UNT / amylase 450 UNT / Bacillus coagulans 1 Billion UNT / protease 450 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543730 | Fallback Solo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1543731 | levonorgestrel 1.5 MG [Fallback Solo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1543732 | levonorgestrel Oral Tablet [Fallback Solo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1543733 | Fallback Solo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1543734 | Fallback Solo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1543735 | Fallback Solo 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543735 | Fallback Solo 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543735 | Fallback Solo 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1543741 | PEG-90 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1543742 | beef tongue preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1543743 | petrolatum 0.59 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1543744 | petrolatum 59 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1543744 | petrolatum 59 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543744 | petrolatum 59 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543745 | histamine dihydrochloride 0.35 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1543746 | capsaicin / histamine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1543747 | capsaicin / histamine Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1543748 | capsaicin / histamine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1543749 | capsaicin 0.375 % / histamine dihydrochloride 0.035 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543749 | capsaicin 0.375 % / histamine dihydrochloride 0.035 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 154375 | Receptor | Designated preferred name (PT) | NO | |
| RxCUI: 154375 | Receptor | Full form of descriptor (FN) | NO | |
| RxCUI: 1543750 | PainMD Max | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1543751 | capsaicin 0.375 MG/ML / histamine dihydrochloride 0.35 MG/ML [PainMD Max] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1543752 | capsaicin / histamine Topical Cream [PainMD Max] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1543753 | PainMD Max Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1543754 | PainMD Max 0.375 % / 0035 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1543754 | PainMD Max 0.375 % / 0035 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1543754 | PainMD Max 0.375 % / 0035 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1543755 | chlorous acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1543773 | PEG-8 caprylic-capric glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 15438 | 5alpha-hydroxysteroid dehydratase | Designated preferred name (PT) | NO | |
| RxCUI: 15438 | 5alpha-hydroxysteroid dehydratase | Full form of descriptor (FN) | NO | |
| RxCUI: 154384 | Reptile venom | Designated preferred name (PT) | NO | |
| RxCUI: 154384 | Reptile venom | Full form of descriptor (FN) | NO | |
| RxCUI: 1543946 | Acticlate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1543948 | doxycycline Oral Tablet [Acticlate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1543949 | Acticlate Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1543950 | Acticlate Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1543953 | Acticlate 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543953 | Acticlate 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543953 | Acticlate 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1543955 | Acticlate 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1543955 | Acticlate 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1543955 | Acticlate 75 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544064 | lidocaine 50 MG/ML [Lidocream] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1544065 | LidoCream5 5 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1544065 | LidoCream5 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544065 | LidoCream5 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544065 | LidoCream5 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544124 | Ecamsule | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544124 | Ecamsule | Designated preferred name (PT) | NO | |
| RxCUI: 1544124 | Ecamsule | Full form of descriptor (FN) | NO | |
| RxCUI: 1544124 | Ecamsule | Designated preferred name (PT) | NO | |
| RxCUI: 1544124 | Ecamsule | Full form of descriptor (FN) | NO | |
| RxCUI: 1544125 | silver fluoride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544128 | Sus scrofa meniscus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544131 | Plectranthus barbatus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544135 | vinylpyrrolidone-eicosene copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1544136 | Bos taurus conjunctiva preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544137 | Bos taurus lymph vessel preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544139 | carbonate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1544140 | ferrous disulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544178 | povidone-iodine 5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544178 | povidone-iodine 5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544178 | povidone-iodine 5 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1544179 | Pro-Tec Gold | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1544180 | povidone-iodine 50 MG/ML [Pro-Tec Gold] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1544181 | povidone-iodine Medicated Shampoo [Pro-Tec Gold] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1544182 | Pro-Tec Gold Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1544183 | PRO-TEC GOLD 5 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1544183 | PRO-TEC GOLD 5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544183 | PRO-TEC GOLD 5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544183 | PRO-TEC GOLD 5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544184 | povidone-iodine 100 MG/ML [Pro-Tec Gold] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1544185 | povidone-iodine Topical Solution [Pro-Tec Gold] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1544186 | Pro-Tec Gold Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1544187 | PRO-TEC GOLD 10 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1544187 | PRO-TEC GOLD 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544187 | PRO-TEC GOLD 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544187 | PRO-TEC GOLD 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544193 | bronopol 2.45 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1544194 | bronopol 0.245 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544194 | bronopol 0.245 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544194 | bronopol 0.245 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1544245 | Bos taurus somatic nerve preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544246 | Centaurium erythraea flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544247 | Imperatoria ostruthia root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544248 | Myristica fragrans whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 154425 | bran 1000 MG Oral Wafer | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1544270 | Syzygium aromaticum fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544271 | sweet marjoram extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544272 | Anemarrhena asphodeloides whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544273 | Ocimum africanum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544274 | hydrolyzed sericin (enzymatic; 2500 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544275 | ethyl glutamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544276 | propylene glycol 1-allyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544280 | nitric oxide 0.5 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1544281 | nitric oxide 5000 PPM Gas for Inhalation | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1544281 | nitric oxide 5000 PPM Gas for Inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544281 | nitric oxide 5000 PPM Gas for Inhalation | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544373 | Renuee | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1544374 | dimethicone 20 MG/ML [Renuee] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1544375 | dimethicone Topical Cream [Renuee] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1544376 | Renuee Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1544377 | Renuee 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1544377 | Renuee 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544377 | Renuee 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544378 | methotrexate 10 MG in 0.2 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544378 | methotrexate 10 MG in 0.2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544378 | methotrexate 10 MG in 0.2 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544378 | methotrexate 10 MG in 0.2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544379 | Rasuvo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1544380 | methotrexate 50 MG/ML [Rasuvo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1544382 | Rasuvo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1544383 | Rasuvo 10 MG in 0.2 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544383 | Rasuvo 10 MG in 0.2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544383 | Rasuvo 10 MG in 0.2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544383 | Rasuvo 10 MG in 0.2 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544383 | Rasuvo 10 MG in 0.2 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544384 | methotrexate 50 MG/ML Auto-Injector [Rasuvo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1544384 | methotrexate 50 MG/ML Auto-Injector [Rasuvo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544384 | methotrexate 50 MG/ML Auto-Injector [Rasuvo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544385 | methotrexate 12.5 MG in 0.25 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544385 | methotrexate 12.5 MG in 0.25 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544385 | methotrexate 12.5 MG in 0.25 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544385 | methotrexate 12.5 MG in 0.25 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544386 | Rasuvo 12.5 MG in 0.25 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544386 | Rasuvo 12.5 MG in 0.25 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544386 | Rasuvo 12.5 MG in 0.25 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544386 | Rasuvo 12.5 MG in 0.25 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544386 | Rasuvo 12.5 MG in 0.25 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544387 | methotrexate 15 MG in 0.3 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544387 | methotrexate 15 MG in 0.3 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544387 | methotrexate 15 MG in 0.3 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544387 | methotrexate 15 MG in 0.3 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544388 | Rasuvo 15 MG in 0.3 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544388 | Rasuvo 15 MG in 0.3 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544388 | Rasuvo 15 MG in 0.3 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544388 | Rasuvo 15 MG in 0.3 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544388 | Rasuvo 15 MG in 0.3 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544389 | methotrexate 17.5 MG in 0.35 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544389 | methotrexate 17.5 MG in 0.35 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544389 | methotrexate 17.5 MG in 0.35 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544389 | methotrexate 17.5 MG in 0.35 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544390 | Rasuvo 17.5 MG in 0.35 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544390 | Rasuvo 17.5 MG in 0.35 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544390 | Rasuvo 17.5 MG in 0.35 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544390 | Rasuvo 17.5 MG in 0.35 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544390 | Rasuvo 17.5 MG in 0.35 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544391 | lead acetate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1544392 | Epigaea repens extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544393 | D&C orange no. 11 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544394 | Rasuvo 20 MG in 0.4 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544394 | Rasuvo 20 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544394 | Rasuvo 20 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544394 | Rasuvo 20 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544394 | Rasuvo 20 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544395 | methotrexate 22.5 MG in 0.45 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544395 | methotrexate 22.5 MG in 0.45 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544395 | methotrexate 22.5 MG in 0.45 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544395 | methotrexate 22.5 MG in 0.45 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544396 | Rasuvo 22.5 MG in 0.45 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544396 | Rasuvo 22.5 MG in 0.45 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544396 | Rasuvo 22.5 MG in 0.45 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544396 | Rasuvo 22.5 MG in 0.45 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544396 | Rasuvo 22.5 MG in 0.45 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544397 | methotrexate 25 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544397 | methotrexate 25 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544397 | methotrexate 25 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544397 | methotrexate 25 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544398 | Rasuvo 25 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544398 | Rasuvo 25 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544398 | Rasuvo 25 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544398 | Rasuvo 25 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544398 | Rasuvo 25 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544399 | methotrexate 27.5 MG in 0.55 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1544399 | methotrexate 27.5 MG in 0.55 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544399 | methotrexate 27.5 MG in 0.55 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544399 | methotrexate 27.5 MG in 0.55 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544400 | Rasuvo 27.5 MG in 0.55 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1544400 | Rasuvo 27.5 MG in 0.55 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544400 | Rasuvo 27.5 MG in 0.55 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544400 | Rasuvo 27.5 MG in 0.55 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544400 | Rasuvo 27.5 MG in 0.55 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544401 | methotrexate 30 MG in 0.6 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544401 | methotrexate 30 MG in 0.6 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544401 | methotrexate 30 MG in 0.6 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544401 | methotrexate 30 MG in 0.6 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544402 | Rasuvo 30 MG in 0.6 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544402 | Rasuvo 30 MG in 0.6 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544402 | Rasuvo 30 MG in 0.6 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544402 | Rasuvo 30 MG in 0.6 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544402 | Rasuvo 30 MG in 0.6 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544403 | methotrexate 7.5 MG in 0.15 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544403 | methotrexate 7.5 MG in 0.15 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544403 | methotrexate 7.5 MG in 0.15 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544403 | methotrexate 7.5 MG in 0.15 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544404 | Rasuvo 7.5 MG in 0.15 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544404 | Rasuvo 7.5 MG in 0.15 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544404 | Rasuvo 7.5 MG in 0.15 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544404 | Rasuvo 7.5 MG in 0.15 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544404 | Rasuvo 7.5 MG in 0.15 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544455 | carprofen 50 MG/ML [Carprieve] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1544456 | carprofen Injectable Solution [Carprieve] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1544457 | Carprieve Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1544458 | carprofen 50 MG/ML Injectable Solution [Carprieve] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544458 | carprofen 50 MG/ML Injectable Solution [Carprieve] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1544460 | idelalisib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1544460 | idelalisib | Designated preferred name (PT) | YES | |
| RxCUI: 1544460 | idelalisib | Full form of descriptor (FN) | YES | |
| RxCUI: 1544460 | idelalisib | Designated preferred name (PT) | YES | |
| RxCUI: 1544460 | idelalisib | Full form of descriptor (FN) | YES | |
| RxCUI: 1544461 | idelalisib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1544462 | idelalisib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1544462 | idelalisib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1544462 | idelalisib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1544463 | idelalisib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1544464 | idelalisib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1544465 | idelalisib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544465 | idelalisib 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1544465 | idelalisib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544465 | idelalisib 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1544466 | Zydelig | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1544467 | idelalisib 100 MG [Zydelig] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1544468 | idelalisib Oral Tablet [Zydelig] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1544469 | Zydelig Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1544470 | Zydelig Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1544471 | Zydelig 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544471 | Zydelig 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544471 | Zydelig 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544472 | idelalisib 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1544473 | idelalisib 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544473 | idelalisib 150 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1544473 | idelalisib 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544473 | idelalisib 150 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1544474 | idelalisib 150 MG [Zydelig] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1544475 | Zydelig 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544475 | Zydelig 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544475 | Zydelig 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544476 | cocoa butter 0.5 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1544477 | cocoa butter 50 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1544477 | cocoa butter 50 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544477 | cocoa butter 50 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544483 | bis-PEG-10 dimethicone dimer dilinoleate copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1544484 | Eichhornia crassipes whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544485 | fumaryl diketopiperazine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1544486 | myreth-4 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544488 | regular insulin, human 8 UNT Inhalation Powder Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544488 | regular insulin, human 8 UNT Inhalation Powder Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544488 | regular insulin, human 8 UNT Inhalation Powder Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544490 | afrezza 8 UNT Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544490 | afrezza 8 UNT Inhalation Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544490 | afrezza 8 UNT Inhalation Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544556 | neomycin sulfate 0.5 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544556 | neomycin sulfate 0.5 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544556 | neomycin sulfate 0.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544556 | neomycin sulfate 0.5 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544568 | regular insulin 90 Inhalation Powder Pack - 60 (4 UNT), 30 (8 UNT) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1544568 | regular insulin 90 Inhalation Powder Pack - 60 (4 UNT), 30 (8 UNT) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544569 | afrezza 90 Inhalation Cartridge Pack - 60 (4 UNT), 30 (8 UNT) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1544569 | afrezza 90 Inhalation Cartridge Pack - 60 (4 UNT), 30 (8 UNT) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544569 | afrezza 90 Inhalation Cartridge Pack - 60 (4 UNT), 30 (8 UNT) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544570 | regular insulin, human 90 Inhalation Powder Pack - 30 (4 UNT), 60 (8 UNT) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1544570 | regular insulin, human 90 Inhalation Powder Pack - 30 (4 UNT), 60 (8 UNT) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544571 | afrezza 90 Inhalation Cartridge Pack - 30 (4 UNT), 60 (8 UNT) | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1544571 | afrezza 90 Inhalation Cartridge Pack - 30 (4 UNT), 60 (8 UNT) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544571 | afrezza 90 Inhalation Cartridge Pack - 30 (4 UNT), 60 (8 UNT) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544575 | dilauryldimonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544577 | Alphaxolone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544577 | Alphaxolone | Designated preferred name (PT) | NO | |
| RxCUI: 1544577 | Alphaxolone | Full form of descriptor (FN) | NO | |
| RxCUI: 1544577 | Alphaxolone | Designated preferred name (PT) | NO | |
| RxCUI: 1544577 | Alphaxolone | Full form of descriptor (FN) | NO | |
| RxCUI: 154462 | Tumor suppressor protein | Designated preferred name (PT) | NO | |
| RxCUI: 154462 | Tumor suppressor protein | Full form of descriptor (FN) | NO | |
| RxCUI: 154462 | Tumor suppressor protein | British preferred term (PTGB) | NO | |
| RxCUI: 1544634 | Cucurbita pepo flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544637 | lidocaine 4 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544637 | lidocaine 4 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544637 | lidocaine 4 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1544638 | lidocaine 40 MG/ML [Anestafoam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1544639 | Anestafoam 4 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544639 | Anestafoam 4 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544639 | Anestafoam 4 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544639 | Anestafoam 4 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1544641 | Omnicide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1544642 | benzalkonium chloride 0.0013 MG/MG [Omnicide] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1544643 | benzalkonium Topical Gel [Omnicide] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1544644 | Omnicide Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1544645 | Omnicide Antimicrobial 0.13 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1544645 | Omnicide Antimicrobial 0.13 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544645 | Omnicide Antimicrobial 0.13 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544645 | Omnicide Antimicrobial 0.13 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544707 | urea 400 MG/ML [Rea-Lo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1544708 | rea lo 40 Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544708 | rea lo 40 Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544708 | rea lo 40 Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544708 | rea lo 40 Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544716 | calamine / pramoxine Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1544717 | calamine 8 % / pramoxine HCl 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544717 | calamine 8 % / pramoxine HCl 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544717 | calamine 8 % / pramoxine HCl 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544718 | urea Topical Lotion [Rea-Lo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1544719 | rea lo 40 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544719 | rea lo 40 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544719 | rea lo 40 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544719 | rea lo 40 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544753 | dantrolene sodium 250 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544753 | dantrolene sodium 250 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544754 | Ryanodex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1544757 | Ryanodex Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1544758 | Ryanodex 250 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544758 | Ryanodex 250 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544758 | Ryanodex 250 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544849 | buprenorphine 4.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1544850 | naloxone 0.7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1544851 | buprenorphine 4.2 MG / naloxone 0.7 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544851 | buprenorphine 4.2 MG / naloxone 0.7 MG Buccal Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544852 | buprenorphine 4.2 MG / naloxone 0.7 MG [Bunavail] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1544853 | Bunavail 4.2 / 0.7 Buccal Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544853 | Bunavail 4.2 / 0.7 Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544853 | Bunavail 4.2 / 0.7 Buccal Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544854 | buprenorphine 6.3 MG / naloxone 1 MG Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544854 | buprenorphine 6.3 MG / naloxone 1 MG Buccal Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544855 | buprenorphine 6.3 MG / naloxone 1 MG [Bunavail] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1544856 | Bunavail 6.3 / 1 Buccal Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544856 | Bunavail 6.3 / 1 Buccal Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544856 | Bunavail 6.3 / 1 Buccal Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1544862 | witch hazel 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1544863 | witch hazel 20 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544863 | witch hazel 20 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544863 | witch hazel 20 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544873 | dextromethorphan HBr 5 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544873 | dextromethorphan HBr 5 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544873 | dextromethorphan HBr 5 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544907 | Puroxcin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1544910 | Puroxcin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1544916 | exenatide 2 MG in 0.65 mL Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1544916 | exenatide 2 MG in 0.65 mL Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544916 | exenatide 2 MG in 0.65 mL Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544918 | Byrdureon 2 MG in 0.65 mL Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544918 | Byrdureon 2 MG in 0.65 mL Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1544918 | Byrdureon 2 MG in 0.65 mL Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544918 | Byrdureon 2 MG in 0.65 mL Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544919 | exenatide 3.08 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1544920 | exenatide 3.08 MG/ML Pen Injector [Bydureon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544920 | exenatide 3.08 MG/ML Pen Injector [Bydureon] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544920 | exenatide 3.08 MG/ML Pen Injector [Bydureon] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1544923 | Epstein-Barr virus immunoglobulin M early antibody | Designated preferred name (PT) | NO | |
| RxCUI: 1544923 | Epstein-Barr virus immunoglobulin M early antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544923 | Epstein-Barr virus immunoglobulin M early antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1544929 | Enterobacter aerogenes | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544930 | Bartonella bacilliformis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544931 | Bartonella clarridgeiae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544932 | Bartonella elizabethae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544933 | Bartonella henselae | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544934 | Bartonella quintana | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544935 | Bartonella vinsonii | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544936 | Bartonella washoensis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544937 | Citrobacter koseri | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 154496 | Transacylase | Designated preferred name (PT) | NO | |
| RxCUI: 154496 | Transacylase | Full form of descriptor (FN) | NO | |
| RxCUI: 1544967 | 2-butyloctyl methacrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1544968 | mineral oil 14 % / petrolatum 71.9 % / phenylephrine HCl 0.25 % / shark liver oil preparation 3 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1544968 | mineral oil 14 % / petrolatum 71.9 % / phenylephrine HCl 0.25 % / shark liver oil preparation 3 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1544968 | mineral oil 14 % / petrolatum 71.9 % / phenylephrine HCl 0.25 % / shark liver oil preparation 3 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1544971 | phenylephrine HCl 0.25 % / shark liver oil preparation 3 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544971 | phenylephrine HCl 0.25 % / shark liver oil preparation 3 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544971 | phenylephrine HCl 0.25 % / shark liver oil preparation 3 % Rectal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1544972 | phenylephrine hydrochloride 2.5 MG/ML / shark liver oil 30 MG/ML [Formulation R] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1544973 | Formulation R 0.25 % / 3 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1544973 | Formulation R 0.25 % / 3 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1544973 | Formulation R 0.25 % / 3 % Rectal Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 154500 | Hydroxy Compound - Ephedrine, Hydroxyzine & Theophylline | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 154500 | Hydroxy Compound - Ephedrine, Hydroxyzine & Theophylline | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545020 | orbifloxacin 22.7 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1545021 | orbifloxacin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1545022 | orbifloxacin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1545023 | orbifloxacin 22.7 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545023 | orbifloxacin 22.7 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545024 | orbifloxacin 22.7 MG [Orbax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1545025 | orbifloxacin Oral Tablet [Orbax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1545026 | Orbax Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1545027 | ORBAX 22.7 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545027 | ORBAX 22.7 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545027 | ORBAX 22.7 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1545028 | orbifloxacin 68 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1545029 | orbifloxacin 68 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545029 | orbifloxacin 68 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545030 | orbifloxacin 68 MG [Orbax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1545031 | ORBAX 68 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545031 | ORBAX 68 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545031 | ORBAX 68 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1545033 | benzoyl peroxide 4.4 % Medicated Liquid Soap (133 ML) / doxycycline monohydrate 100 MG oral tablet (30) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1545033 | benzoyl peroxide 4.4 % Medicated Liquid Soap (133 ML) / doxycycline monohydrate 100 MG oral tablet (30) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545034 | Benoxyldoxy 30 Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1545034 | Benoxyldoxy 30 Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545034 | Benoxyldoxy 30 Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545035 | benzoyl peroxide 4.4 % Medicated Liquid Soap (133 ML) / doxycycline monohydrate 100 MG oral tablet (60) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1545035 | benzoyl peroxide 4.4 % Medicated Liquid Soap (133 ML) / doxycycline monohydrate 100 MG oral tablet (60) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545036 | Benoxyldoxy 60 Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1545036 | Benoxyldoxy 60 Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545036 | Benoxyldoxy 60 Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545037 | Abies alba leafy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545038 | Anamirta cocculus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545039 | Bos taurus colon preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545040 | poison hemlock root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545040 | poison hemlock root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545041 | Ovis aries testicle preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545042 | Verbascum thapsus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1545043 | lead carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545045 | Product containing precisely vemurafenib 240 milligram/1 each conventional release oral capsule (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 1545045 | Product containing precisely vemurafenib 240 milligram/1 each conventional release oral capsule (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 1545046 | ferric sulfate Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1545047 | ferric sulfate Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1545048 | ferric sulfate 20 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1545048 | ferric sulfate 20 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545048 | ferric sulfate 20 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545050 | Amfetamine and/or amfetamine derivative | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545050 | Amfetamine and/or amfetamine derivative | Full form of descriptor (FN) | NO | |
| RxCUI: 1545050 | Amfetamine and/or amfetamine derivative | Designated preferred name (PT) | NO | |
| RxCUI: 1545051 | Substance with B-Raf inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1545051 | Substance with B-Raf inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1545051 | Substance with B-Raf inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1545051 | Substance with B-Raf inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545051 | Substance with B-Raf inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1545054 | Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1545054 | Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1545054 | Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1545054 | Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545054 | Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1545063 | Tafamidis | Full form of descriptor (FN) | YES | |
| RxCUI: 1545063 | Tafamidis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1545063 | Tafamidis | Designated preferred name (PT) | YES | |
| RxCUI: 1545063 | Tafamidis | Full form of descriptor (FN) | YES | |
| RxCUI: 1545063 | Tafamidis | Designated preferred name (PT) | YES | |
| RxCUI: 1545065 | tafamidis Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1545065 | tafamidis Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1545065 | tafamidis Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1545066 | tafamidis Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1545067 | tafamidis Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 154509 | Farnesyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 154509 | Farnesyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 154509 | Farnesyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154509 | Farnesyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545142 | colloidal oatmeal 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545142 | colloidal oatmeal 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545142 | colloidal oatmeal 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545143 | phenylephrine / zinc oxide Rectal Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1545144 | phenylephrine HCl 0.25 % / zinc oxide 12.5 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545144 | phenylephrine HCl 0.25 % / zinc oxide 12.5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545144 | phenylephrine HCl 0.25 % / zinc oxide 12.5 % Rectal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545144 | phenylephrine HCl 0.25 % / zinc oxide 12.5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545145 | canagliflozin 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1545146 | canagliflozin / metFORMIN Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1545146 | canagliflozin / metFORMIN Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545146 | canagliflozin / metFORMIN Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1545146 | canagliflozin / metFORMIN Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1545147 | canagliflozin / metFORMIN Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1545147 | canagliflozin / metFORMIN Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545148 | canagliflozin / metFORMIN Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1545148 | canagliflozin / metFORMIN Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545149 | canagliflozin / metFORMIN | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1545149 | canagliflozin / metFORMIN | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545149 | canagliflozin / metFORMIN | Designated preferred name (PT) | YES | |
| RxCUI: 1545149 | canagliflozin / metFORMIN | Full form of descriptor (FN) | YES | |
| RxCUI: 1545150 | canagliflozin 150 MG / metFORMIN HCl 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545150 | canagliflozin 150 MG / metFORMIN HCl 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1545150 | canagliflozin 150 MG / metFORMIN HCl 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545151 | Invokamet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1545152 | canagliflozin 150 MG / metFORMIN hydrochloride 1000 MG [Invokamet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1545152 | canagliflozin 150 MG / metFORMIN hydrochloride 1000 MG [Invokamet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545153 | canagliflozin / metFORMIN Oral Tablet [Invokamet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1545153 | canagliflozin / metFORMIN Oral Tablet [Invokamet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545154 | Invokamet Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1545155 | Invokamet Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1545156 | Invokamet 150 MG / 1000 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1545156 | Invokamet 150 MG / 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545156 | Invokamet 150 MG / 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545156 | Invokamet 150 MG / 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545156 | Invokamet 150 MG / 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545157 | canagliflozin 150 MG / metFORMIN HCl 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545157 | canagliflozin 150 MG / metFORMIN HCl 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1545157 | canagliflozin 150 MG / metFORMIN HCl 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545158 | canagliflozin 150 MG / metFORMIN hydrochloride 500 MG [Invokamet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1545158 | canagliflozin 150 MG / metFORMIN hydrochloride 500 MG [Invokamet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545159 | Invokamet 150 MG / 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1545159 | Invokamet 150 MG / 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545159 | Invokamet 150 MG / 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545159 | Invokamet 150 MG / 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545159 | Invokamet 150 MG / 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545160 | canagliflozin 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1545161 | canagliflozin 50 MG / metFORMIN HCl 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545161 | canagliflozin 50 MG / metFORMIN HCl 1000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1545161 | canagliflozin 50 MG / metFORMIN HCl 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545162 | canagliflozin 50 MG / metFORMIN hydrochloride 1000 MG [Invokamet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1545162 | canagliflozin 50 MG / metFORMIN hydrochloride 1000 MG [Invokamet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545163 | Invokamet 50 MG / 1000 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1545163 | Invokamet 50 MG / 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545163 | Invokamet 50 MG / 1000 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545163 | Invokamet 50 MG / 1000 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545163 | Invokamet 50 MG / 1000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545164 | canagliflozin 50 MG / metFORMIN HCl 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545164 | canagliflozin 50 MG / metFORMIN HCl 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1545164 | canagliflozin 50 MG / metFORMIN HCl 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545165 | canagliflozin 50 MG / metFORMIN hydrochloride 500 MG [Invokamet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1545165 | canagliflozin 50 MG / metFORMIN hydrochloride 500 MG [Invokamet] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545166 | Invokamet 50 MG / 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1545166 | Invokamet 50 MG / 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545166 | Invokamet 50 MG / 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545166 | Invokamet 50 MG / 500 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545166 | Invokamet 50 MG / 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545167 | N-tert-octylacrylamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545168 | ceteareth-2 phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1545169 | ceteareth-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1545170 | Apis cerana whole preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545171 | hydrocortisone acetate 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1545172 | hydrocortisone acetate 10 % Rectal Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545172 | hydrocortisone acetate 10 % Rectal Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545172 | hydrocortisone acetate 10 % Rectal Foam | Designated preferred name (PT) | YES | |
| RxCUI: 1545172 | hydrocortisone acetate 10 % Rectal Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1545172 | hydrocortisone acetate 10 % Rectal Foam | Full form of descriptor (FN) | YES | |
| RxCUI: 1545173 | hydrocortisone acetate 100 MG/ML [Cortifoam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1545174 | cortifoam 10 % Rectal Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545174 | cortifoam 10 % Rectal Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545174 | cortifoam 10 % Rectal Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545174 | cortifoam 10 % Rectal Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1545290 | lidocaine HCl 5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545290 | lidocaine HCl 5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545290 | lidocaine HCl 5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545291 | lidocaine hydrochloride 50 MG/ML [Derma Numb] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1545292 | Derma Numb 5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545292 | Derma Numb 5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545292 | Derma Numb 5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545292 | Derma Numb 5 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1545293 | menthol 1.25 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545293 | menthol 1.25 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545293 | menthol 1.25 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545294 | lidocaine hydrochloride 24.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1545295 | lidocaine HCl 2.46 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545295 | lidocaine HCl 2.46 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545296 | lidocaine hydrochloride 24.6 MG/ML [Hexa-Caine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1545297 | Hexa-Caine Anti-Itch 2.46 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545297 | Hexa-Caine Anti-Itch 2.46 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545297 | Hexa-Caine Anti-Itch 2.46 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545297 | Hexa-Caine Anti-Itch 2.46 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1545298 | Afterpill | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1545299 | levonorgestrel 1.5 MG [Afterpill] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1545300 | levonorgestrel Oral Tablet [Afterpill] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1545301 | Afterpill Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1545302 | Afterpill Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1545303 | AfterPill 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545303 | AfterPill 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545303 | AfterPill 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1545304 | dexbrompheniramine Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1545305 | dexbrompheniramine Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1545306 | dexbrompheniramine maleate 1 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545306 | dexbrompheniramine maleate 1 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1545307 | dexbrompheniramine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1545308 | dexbrompheniramine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1545309 | dexbrompheniramine maleate 2 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1545309 | dexbrompheniramine maleate 2 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545309 | dexbrompheniramine maleate 2 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545358 | PEG-20 glyceryl triisostearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 154558 | Beta-lactamase | Designated preferred name (PT) | NO | |
| RxCUI: 154558 | Beta-lactamase | Full form of descriptor (FN) | NO | |
| RxCUI: 1545650 | simethicone Chewable Tablet [Dulcogas] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1545651 | Dulcogas Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1545652 | Dulcogas 125 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545652 | Dulcogas 125 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545652 | Dulcogas 125 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1545653 | empagliflozin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1545653 | empagliflozin | Designated preferred name (PT) | YES | |
| RxCUI: 1545653 | empagliflozin | Full form of descriptor (FN) | YES | |
| RxCUI: 1545653 | empagliflozin | Designated preferred name (PT) | YES | |
| RxCUI: 1545653 | empagliflozin | Full form of descriptor (FN) | YES | |
| RxCUI: 1545654 | empagliflozin 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1545655 | empagliflozin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1545655 | empagliflozin Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1545655 | empagliflozin Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1545656 | empagliflozin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1545657 | empagliflozin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1545658 | empagliflozin 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545658 | empagliflozin 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1545658 | empagliflozin 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1545658 | empagliflozin 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1545659 | Jardiance | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1545660 | empagliflozin 10 MG [Jardiance] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1545661 | empagliflozin Oral Tablet [Jardiance] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1545662 | Jardiance Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1545663 | Jardiance Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1545664 | Jardiance 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1545664 | Jardiance 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545664 | Jardiance 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545665 | empagliflozin 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1545666 | empagliflozin 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545666 | empagliflozin 25 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1545666 | empagliflozin 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1545666 | empagliflozin 25 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1545667 | empagliflozin 25 MG [Jardiance] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1545668 | Jardiance 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1545668 | Jardiance 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545668 | Jardiance 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545669 | phenylephrine HCl 0.25 % / shark liver oil 3 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545669 | phenylephrine HCl 0.25 % / shark liver oil 3 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545669 | phenylephrine HCl 0.25 % / shark liver oil 3 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545671 | benzalkonium Topical Foam [Veteran Shield 24] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1545672 | Veteran Shield 24 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1545673 | Veteran Shield 24 0.1 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1545673 | Veteran Shield 24 0.1 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545673 | Veteran Shield 24 0.1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545673 | Veteran Shield 24 0.1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545674 | Elta Seal Moisture Barrier | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1545675 | zinc oxide 60 MG/ML [Elta Seal Moisture Barrier] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1545676 | zinc oxide Topical Cream [Elta Seal Moisture Barrier] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1545677 | Elta Seal Moisture Barrier Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1545678 | Elta Seal Moisture Barrier 6 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545678 | Elta Seal Moisture Barrier 6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545678 | Elta Seal Moisture Barrier 6 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1545678 | Elta Seal Moisture Barrier 6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545680 | Cervus elaphus whole preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545681 | Cichorium intybus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545682 | Colchicum autumnale whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545683 | Krameria lappacea whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545684 | Ononis repens root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545685 | phenyl butyrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545687 | benzalkonium / lidocaine Topical Spray [Bactine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1545688 | Bactine 0.13 % / 2.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545688 | Bactine 0.13 % / 2.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545688 | Bactine 0.13 % / 2.5 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 15457 | Cytokinin synthase | Designated preferred name (PT) | NO | |
| RxCUI: 15457 | Cytokinin synthase | Full form of descriptor (FN) | NO | |
| RxCUI: 15457 | Cytokinin synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545702 | capsaicin 1.5 MG/ML [Capzasin-P] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1545703 | Capzasin-P 0.15 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1545703 | Capzasin-P 0.15 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545703 | Capzasin-P 0.15 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545703 | Capzasin-P 0.15 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545708 | methylprednisolone acetate 40 ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1545708 | methylprednisolone acetate 40 ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545709 | methylprednisolone acetate 40 ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545709 | methylprednisolone acetate 40 ML Injectable Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545711 | methylprednisolone acetate 40 ML [Depo-Medrol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1545711 | methylprednisolone acetate 40 ML [Depo-Medrol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545712 | methylprednisolone acetate 40 ML Injectable Suspension [Depo-Medrol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545712 | methylprednisolone acetate 40 ML Injectable Suspension [Depo-Medrol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545712 | methylprednisolone acetate 40 ML Injectable Suspension [Depo-Medrol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1545712 | methylprednisolone acetate 40 ML Injectable Suspension [Depo-Medrol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545716 | benzethonium Cl 0.2 % / lidocaine 4 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1545716 | benzethonium Cl 0.2 % / lidocaine 4 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545716 | benzethonium Cl 0.2 % / lidocaine 4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545771 | Gleostine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1545772 | lomustine 10 MG [Gleostine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1545773 | lomustine Oral Capsule [Gleostine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1545774 | Gleostine Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1545775 | Gleostine Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1545776 | Gleostine 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545776 | Gleostine 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545776 | Gleostine 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1545777 | lomustine 100 MG [Gleostine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1545778 | Gleostine 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545778 | Gleostine 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545778 | Gleostine 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1545779 | lomustine 40 MG [Gleostine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1545780 | Gleostine 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1545780 | Gleostine 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545780 | Gleostine 40 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1545787 | benzalkonium chloride 0.13 % / benzocaine 7.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545787 | benzalkonium chloride 0.13 % / benzocaine 7.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545787 | benzalkonium chloride 0.13 % / benzocaine 7.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545788 | benzalkonium chloride 1.3 MG/ML / benzocaine 75 MG/ML [Viroxyn] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1545789 | benzalkonium chloride 1.3 MG/ML / benzocaine 75 MG/ML Topical Solution [Viroxyn] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1545789 | benzalkonium chloride 1.3 MG/ML / benzocaine 75 MG/ML Topical Solution [Viroxyn] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545790 | Daphne mezereum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545791 | Populus tremula whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545792 | chrysosplenetin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545794 | carbon dioxide 7 % / oxygen 33 % Gas for Inhalation | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545794 | carbon dioxide 7 % / oxygen 33 % Gas for Inhalation | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545800 | castor oil 788 MG/ML / Peruvian balsam 87 MG/ML / trypsin 0.12 MG/ML [Granulex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1545801 | Granulex (0.12 MG / 87 MG / 788 MG) per GM Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1545801 | Granulex (0.12 MG / 87 MG / 788 MG) per GM Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545801 | Granulex (0.12 MG / 87 MG / 788 MG) per GM Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545898 | naloxone hydrochloride 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1545899 | Naloxone- and oxycodone-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1545899 | Naloxone- and oxycodone-containing product in oral dose form | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545899 | Naloxone- and oxycodone-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 1545899 | Naloxone- and oxycodone-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 1545900 | naloxone / oxycodone Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1545900 | naloxone / oxycodone Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545901 | naloxone / oxycodone Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1545901 | naloxone / oxycodone Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545902 | Product containing naloxone and oxycodone (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1545902 | Product containing naloxone and oxycodone (medicinal product) | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545902 | Product containing naloxone and oxycodone (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 1545902 | Product containing naloxone and oxycodone (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 1545903 | oxycodone HCl 20 MG / naloxone HCl 10 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545903 | oxycodone HCl 20 MG / naloxone HCl 10 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545903 | oxycodone HCl 20 MG / naloxone HCl 10 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545903 | oxycodone HCl 20 MG / naloxone HCl 10 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545904 | naloxone hydrochloride 10 MG / oxycodone hydrochloride 20 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545904 | naloxone hydrochloride 10 MG / oxycodone hydrochloride 20 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545906 | naloxone hydrochloride 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1545907 | oxycodone HCl 40 MG / naloxone HCl 20 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545907 | oxycodone HCl 40 MG / naloxone HCl 20 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545907 | oxycodone HCl 40 MG / naloxone HCl 20 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545907 | oxycodone HCl 40 MG / naloxone HCl 20 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545908 | naloxone hydrochloride 20 MG / oxycodone hydrochloride 40 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545908 | naloxone hydrochloride 20 MG / oxycodone hydrochloride 40 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545909 | naloxone hydrochloride 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1545910 | naloxone HCl 5 MG / oxyCODONE HCl 10 MG 12 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545910 | naloxone HCl 5 MG / oxyCODONE HCl 10 MG 12 HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545910 | naloxone HCl 5 MG / oxyCODONE HCl 10 MG 12 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545910 | naloxone HCl 5 MG / oxyCODONE HCl 10 MG 12 HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545911 | naloxone hydrochloride 5 MG / oxycodone hydrochloride 10 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545911 | naloxone hydrochloride 5 MG / oxycodone hydrochloride 10 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1545912 | Sedum roseum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1545918 | dimethicone 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1545918 | dimethicone 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1545918 | dimethicone 1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1545975 | cefadroxil anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1545975 | cefadroxil anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1545975 | cefadroxil anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1545976 | codeine anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1545982 | carbidopa anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1545982 | carbidopa anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1545982 | carbidopa anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1545984 | ceftazidime anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1545984 | ceftazidime anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1545984 | ceftazidime anhydrous | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545984 | ceftazidime anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1545986 | Imipenem anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1545986 | Imipenem anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1545986 | Imipenem anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1545987 | ethiofos anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1545987 | ethiofos anhydrous | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545988 | cyclophosphamide anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1545988 | cyclophosphamide anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1545988 | cyclophosphamide anhydrous | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1545988 | cyclophosphamide anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1545989 | enalaprilat anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1545992 | doxycycline anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1545992 | doxycycline anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1545992 | doxycycline anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1545996 | Anhydrous methyldopa | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1545996 | Anhydrous methyldopa | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1545996 | Anhydrous methyldopa | Designated preferred name (PT) | YES | |
| RxCUI: 1545996 | Anhydrous methyldopa | Full form of descriptor (FN) | YES | |
| RxCUI: 1545999 | oxytetracycline anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1545999 | oxytetracycline anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1545999 | oxytetracycline anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1546000 | Piperacillin anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546000 | Piperacillin anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1546000 | Piperacillin anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1546004 | timolol anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546005 | thioguanine anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546007 | cidofovir anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546009 | levofloxacin anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546009 | levofloxacin anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1546009 | levofloxacin anhydrous | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1546009 | levofloxacin anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1546014 | zoledronic acid anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546014 | zoledronic acid anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1546014 | zoledronic acid anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1546015 | regadenoson anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546017 | tenofovir anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546019 | dasatinib anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546019 | dasatinib anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1546019 | dasatinib anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1546020 | cefprozil anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546021 | Cefixime anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546021 | Cefixime anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1546021 | Cefixime anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1546022 | lisinopril anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546022 | lisinopril anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1546022 | lisinopril anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1546024 | indinavir anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546025 | gatifloxacin anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546027 | entecavir anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546027 | entecavir anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1546027 | entecavir anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1546028 | mercaptopurine anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546029 | meropenem anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546029 | meropenem anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1546029 | meropenem anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1546030 | saxagliptin anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546030 | saxagliptin anhydrous | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1546031 | canagliflozin anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546031 | canagliflozin anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1546031 | canagliflozin anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1546032 | hexylcaine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546033 | hexylcaine hydrochloride 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1546034 | hexylcaine HCl 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546034 | hexylcaine HCl 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546034 | hexylcaine HCl 5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546035 | tetracaine hydrochloride 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1546036 | tetracaine HCl 0.5 % Topical Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 1546036 | tetracaine HCl 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546036 | tetracaine HCl 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546036 | tetracaine HCl 0.5 % Topical Solution | Designated preferred name (PT) | NO | |
| RxCUI: 1546036 | tetracaine HCl 0.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546037 | tetracycline hydrochloride 2.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1546038 | tetracycline HCl 2.2 MG/ML Topical Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 1546038 | tetracycline HCl 2.2 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546038 | tetracycline HCl 2.2 MG/ML Topical Solution | Designated preferred name (PT) | NO | |
| RxCUI: 1546038 | tetracycline HCl 2.2 MG/ML Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546039 | tetracycline hydrochloride 2.2 MG/ML [Topicycline] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1546040 | Topicycline 2.2 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546040 | Topicycline 2.2 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546050 | furosemide 12.5 MG [Disal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1546051 | furosemide Oral Tablet [Disal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1546052 | Disal Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1546053 | Disal Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1546054 | Disal 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546054 | Disal 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546054 | Disal 12.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546055 | furosemide 50 MG [Disal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1546056 | Disal 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546056 | Disal 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546056 | Disal 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546059 | olodaterol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546059 | olodaterol | Designated preferred name (PT) | YES | |
| RxCUI: 1546059 | olodaterol | Full form of descriptor (FN) | YES | |
| RxCUI: 1546059 | olodaterol | Designated preferred name (PT) | YES | |
| RxCUI: 1546059 | olodaterol | Full form of descriptor (FN) | YES | |
| RxCUI: 1546061 | olodaterol Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1546061 | olodaterol Inhalant Product | Designated preferred name (PT) | YES | |
| RxCUI: 1546061 | olodaterol Inhalant Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1546064 | Striverdi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1546067 | Striverdi Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1546073 | lidocaine hydrochloride 45 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1546074 | lidocaine HCl 4.5 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546074 | lidocaine HCl 4.5 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546074 | lidocaine HCl 4.5 % Rectal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546076 | olodaterol 0.0025 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1546077 | olodaterol 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546077 | olodaterol 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546077 | olodaterol 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546078 | olodaterol 0.0025 MG/ACTUAT [Striverdi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1546079 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546079 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546079 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546079 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546079 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546079 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 28 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546080 | olodaterol 0.0025 MG/ACTUAT Metered Dose Inhalation Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546080 | olodaterol 0.0025 MG/ACTUAT Metered Dose Inhalation Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546081 | olodaterol 0.0025 MG/ACTUAT Inhalation Spray [Striverdi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546081 | olodaterol 0.0025 MG/ACTUAT Inhalation Spray [Striverdi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546081 | olodaterol 0.0025 MG/ACTUAT Inhalation Spray [Striverdi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546081 | olodaterol 0.0025 MG/ACTUAT Inhalation Spray [Striverdi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546082 | olodaterol 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1546082 | olodaterol 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546082 | olodaterol 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546083 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1546083 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546083 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546083 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546083 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546083 | Striverdi Respimat 2.5 MCG/ACTUAT Metered Dose Inhalation Spray, 60 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546084 | Targiniq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1546085 | naloxone hydrochloride 5 MG / oxycodone hydrochloride 10 MG [Targiniq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1546085 | naloxone hydrochloride 5 MG / oxycodone hydrochloride 10 MG [Targiniq] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1546086 | naloxone / oxycodone Extended Release Oral Tablet [Targiniq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1546086 | naloxone / oxycodone Extended Release Oral Tablet [Targiniq] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1546087 | Targiniq Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1546088 | Targiniq Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1546089 | Targiniq 10 MG / 5 MG 12HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546089 | Targiniq 10 MG / 5 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1546089 | Targiniq 10 MG / 5 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546089 | Targiniq 10 MG / 5 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546090 | naloxone hydrochloride 5 MG / oxycodone hydrochloride 10 MG Extended Release Oral Tablet [Targiniq] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546090 | naloxone hydrochloride 5 MG / oxycodone hydrochloride 10 MG Extended Release Oral Tablet [Targiniq] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1546102 | camphor 0.2 % / menthol 4 % / methyl salicylate 12.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546102 | camphor 0.2 % / menthol 4 % / methyl salicylate 12.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546102 | camphor 0.2 % / menthol 4 % / methyl salicylate 12.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154614 | Dihydroxyphenylalanine decarboxylase inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154614 | Dihydroxyphenylalanine decarboxylase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 154614 | Dihydroxyphenylalanine decarboxylase inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154614 | Dihydroxyphenylalanine decarboxylase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 1546161 | alanine, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546162 | aluminum cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546163 | ivermectin 5 MG/ML [Bimectin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1546164 | Bimectin Pour-On 5 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546164 | Bimectin Pour-On 5 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546164 | Bimectin Pour-On 5 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546165 | amprolium ion | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546166 | aprolium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546167 | antimony cation (3+) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546168 | peginterferon beta-1a | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546168 | peginterferon beta-1a | Designated preferred name (PT) | YES | |
| RxCUI: 1546168 | peginterferon beta-1a | Full form of descriptor (FN) | YES | |
| RxCUI: 1546168 | peginterferon beta-1a | Designated preferred name (PT) | YES | |
| RxCUI: 1546168 | peginterferon beta-1a | Full form of descriptor (FN) | YES | |
| RxCUI: 1546169 | peginterferon beta-1a 0.188 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1546170 | peginterferon beta-1a Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1546170 | peginterferon beta-1a Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 1546170 | peginterferon beta-1a Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1546171 | peginterferon beta-1a Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1546172 | peginterferon beta-1a 94 MCG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1546172 | peginterferon beta-1a 94 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546172 | peginterferon beta-1a 94 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546173 | Plegridy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1546174 | peginterferon beta-1a 0.188 MG/ML [Plegridy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1546175 | peginterferon beta-1a Prefilled Syringe [Plegridy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1546176 | Plegridy Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1546177 | Plegridy 94 MCG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1546177 | Plegridy 94 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546177 | Plegridy 94 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546177 | Plegridy 94 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546178 | peginterferon beta-1a 0.188 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546179 | peginterferon beta-1a 0.188 MG/ML Prefilled Syringe [Plegridy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546179 | peginterferon beta-1a 0.188 MG/ML Prefilled Syringe [Plegridy] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546180 | peginterferon beta-1a 0.126 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1546181 | peginterferon beta-1a 63 MCG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1546181 | peginterferon beta-1a 63 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546181 | peginterferon beta-1a 63 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546181 | peginterferon beta-1a 63 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546182 | peginterferon beta-1a 0.126 MG/ML [Plegridy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1546183 | Plegridy 63 MCG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1546183 | Plegridy 63 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546183 | Plegridy 63 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546183 | Plegridy 63 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546184 | peginterferon beta-1a 0.126 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546185 | peginterferon beta-1a 0.126 MG/ML Prefilled Syringe [Plegridy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546185 | peginterferon beta-1a 0.126 MG/ML Prefilled Syringe [Plegridy] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546186 | peginterferon beta-1a 0.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1546187 | peginterferon beta-1a 125 MCG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1546187 | peginterferon beta-1a 125 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546187 | peginterferon beta-1a 125 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546187 | peginterferon beta-1a 125 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546188 | peginterferon beta-1a 0.25 MG/ML [Plegridy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1546189 | Plegridy 125 MCG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1546189 | Plegridy 125 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546189 | Plegridy 125 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546189 | Plegridy 125 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546190 | peginterferon beta-1a 0.25 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546191 | peginterferon beta-1a 0.25 MG/ML Prefilled Syringe [Plegridy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546191 | peginterferon beta-1a 0.25 MG/ML Prefilled Syringe [Plegridy] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546194 | gentamicin sulfate 3 MG / betamethasone valerate 1 MG in 1 ML Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546194 | gentamicin sulfate 3 MG / betamethasone valerate 1 MG in 1 ML Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546194 | gentamicin sulfate 3 MG / betamethasone valerate 1 MG in 1 ML Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546195 | ivermectin 10 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546196 | benazeprilat | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546197 | peginterferon beta-1a 63 MCG in 0.5 ML (1) Prefilled Syringe / peginterferon beta-1a 94 MCG in 0.5 ML (1) Prefilled Syringe Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1546197 | peginterferon beta-1a 63 MCG in 0.5 ML (1) Prefilled Syringe / peginterferon beta-1a 94 MCG in 0.5 ML (1) Prefilled Syringe Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546198 | Plegridy Starter Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1546198 | Plegridy Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546198 | Plegridy Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546201 | hydrogen peroxide / lactate Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1546202 | hydrogen peroxide 0.5 % / lactic acid 1.7 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546202 | hydrogen peroxide 0.5 % / lactic acid 1.7 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546202 | hydrogen peroxide 0.5 % / lactic acid 1.7 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546203 | hydrogen peroxide / lactate Topical Spray [Astri-UC] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1546204 | ASTRI-UC 0.5 % / 1.7 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546204 | ASTRI-UC 0.5 % / 1.7 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546204 | ASTRI-UC 0.5 % / 1.7 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546205 | Hirudin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546205 | Hirudin | Designated preferred name (PT) | NO | |
| RxCUI: 1546205 | Hirudin | Full form of descriptor (FN) | NO | |
| RxCUI: 1546206 | Croton tiglium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546207 | argatroban anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546207 | argatroban anhydrous | Designated preferred name (PT) | YES | |
| RxCUI: 1546207 | argatroban anhydrous | Full form of descriptor (FN) | YES | |
| RxCUI: 1546208 | barium citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546209 | ethyl methylphenylglycidate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546210 | gold monosulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546211 | povidone-iodine 7.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1546212 | povidone-iodine 0.75 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546212 | povidone-iodine 0.75 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546212 | povidone-iodine 0.75 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1546217 | EPINEPHrine 0.22 MG Inhalation Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546217 | EPINEPHrine 0.22 MG Inhalation Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546217 | EPINEPHrine 0.22 MG Inhalation Powder | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1546223 | diatrizoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546231 | carbamide peroxide Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1546232 | carbamide peroxide 15 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546232 | carbamide peroxide 15 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546232 | carbamide peroxide 15 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546238 | sodium monofluorophosphate 0.88 % Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546238 | sodium monofluorophosphate 0.88 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546238 | sodium monofluorophosphate 0.88 % Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546238 | sodium monofluorophosphate 0.88 % Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546239 | sodium fluoride 0.011 MG/MG [FluoriSHIELD] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 154624 | Substance with topoisomerase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 154624 | Substance with topoisomerase inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154624 | Substance with topoisomerase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 154624 | Substance with topoisomerase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 154624 | Substance with topoisomerase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1546240 | sodium fluoride 0.011 MG/MG Oral Gel [FluoriSHIELD] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546240 | sodium fluoride 0.011 MG/MG Oral Gel [FluoriSHIELD] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546240 | sodium fluoride 0.011 MG/MG Oral Gel [FluoriSHIELD] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546249 | menthol 35 MG/ML [DynaFreeze] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 154625 | Inhalant | Dose Form (DF) | NO | |
| RxCUI: 1546250 | dynaFREEZE 3.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546250 | dynaFREEZE 3.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546250 | dynaFREEZE 3.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546253 | testosterone 12.5 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1546254 | testosterone 12.5 MG/ACTUAT Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546255 | testosterone 12.5 MG/ACTUAT [Vogelxo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1546256 | testosterone 12.5 MG/ACTUAT Topical Gel [Vogelxo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546256 | testosterone 12.5 MG/ACTUAT Topical Gel [Vogelxo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546256 | testosterone 12.5 MG/ACTUAT Topical Gel [Vogelxo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546256 | testosterone 12.5 MG/ACTUAT Topical Gel [Vogelxo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546258 | Venous plasma | Designated preferred name (PT) | NO | |
| RxCUI: 1546258 | Venous plasma | Full form of descriptor (FN) | NO | |
| RxCUI: 1546264 | zinc cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546265 | lithium cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546266 | iodide I-125 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546268 | thiamine ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546269 | uranium cation (6+) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 154627 | Pancreatic elastase II | Designated preferred name (PT) | NO | |
| RxCUI: 154627 | Pancreatic elastase II | Full form of descriptor (FN) | NO | |
| RxCUI: 1546270 | radium cation | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546271 | nitrate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546272 | manganese cation (2+) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546273 | fluoride ion F-18 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546274 | bromide ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546275 | iodide ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546276 | cadmium cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546277 | bicarbonate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546278 | strontium cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546279 | oseltamivir acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546279 | oseltamivir acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546280 | nickel cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546281 | indium cation In-111 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546282 | gallium cation | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546283 | antimony cation (5+) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546284 | bismuth cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546288 | GentaCalm 0.057 % / 0.0284 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546288 | GentaCalm 0.057 % / 0.0284 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546288 | GentaCalm 0.057 % / 0.0284 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546324 | Pseudonaja textilis antivenom | Designated preferred name (PT) | NO | |
| RxCUI: 1546324 | Pseudonaja textilis antivenom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546324 | Pseudonaja textilis antivenom | Full form of descriptor (FN) | NO | |
| RxCUI: 1546329 | dienogest Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1546329 | dienogest Oral Product | Designated preferred name (PT) | NO | |
| RxCUI: 1546329 | dienogest Oral Product | Full form of descriptor (FN) | NO | |
| RxCUI: 1546330 | dienogest Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1546331 | dienogest Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1546332 | dienogest 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546332 | dienogest 2 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 1546332 | dienogest 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546332 | dienogest 2 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 1546337 | Pseudechis australis antivenom | Designated preferred name (PT) | NO | |
| RxCUI: 1546337 | Pseudechis australis antivenom | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546337 | Pseudechis australis antivenom | Full form of descriptor (FN) | NO | |
| RxCUI: 1546339 | Pholcodine citrate | Designated preferred name (PT) | NO | |
| RxCUI: 1546339 | Pholcodine citrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1546341 | Piperilate ethobromide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546341 | Piperilate ethobromide | Designated preferred name (PT) | NO | |
| RxCUI: 1546341 | Piperilate ethobromide | Full form of descriptor (FN) | NO | |
| RxCUI: 1546349 | ulipristal acetate 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1546350 | ulipristal acetate 5 MG Oral Tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 1546350 | ulipristal acetate 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546350 | ulipristal acetate 5 MG Oral Tablet | Designated preferred name (PT) | NO | |
| RxCUI: 1546350 | ulipristal acetate 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546351 | 1,2-dimyristoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (sodium salt) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546352 | 2,3-dimercapto-1-propanesulfonic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546353 | 2-ethylhexyl 4-phenylbenzophenone-2'-carboxylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546354 | 2-mercaptoethanesulfonic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546355 | 4,4'-dinitrocarbanilide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546356 | Dabigatran | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546356 | Dabigatran | Designated preferred name (PT) | YES | |
| RxCUI: 1546356 | Dabigatran | Full form of descriptor (FN) | YES | |
| RxCUI: 1546356 | Dabigatran | Designated preferred name (PT) | YES | |
| RxCUI: 1546356 | Dabigatran | Full form of descriptor (FN) | YES | |
| RxCUI: 1546357 | Iron III ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546357 | Iron III ion | Designated preferred name (PT) | YES | |
| RxCUI: 1546357 | Iron III ion | Full form of descriptor (FN) | YES | |
| RxCUI: 1546357 | Iron III ion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546358 | moexiprilat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546359 | quinaprilat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546360 | zinc valerate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546361 | zinc picrate nonahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546362 | zinc picrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546363 | Verbascum densiflorum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546364 | triiodide ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546365 | pralidoxime cation | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546366 | selenate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546367 | brilliant green cation | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546368 | cesium cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546369 | gentian violet cation | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546370 | thallous cation Tl-201 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546371 | gallium cation Ga-67 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546372 | 67-Ga | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546372 | 67-Ga | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546372 | 67-Ga | Designated preferred name (PT) | NO | |
| RxCUI: 1546372 | 67-Ga | Full form of descriptor (FN) | NO | |
| RxCUI: 1546372 | 67-Ga | Designated preferred name (PT) | NO | |
| RxCUI: 1546372 | 67-Ga | Full form of descriptor (FN) | NO | |
| RxCUI: 1546373 | ipratropium cation | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546374 | gold cation (3+) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546375 | lithium hydroxide anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546376 | Lithium hydroxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546376 | Lithium hydroxide | Designated preferred name (PT) | NO | |
| RxCUI: 1546376 | Lithium hydroxide | Full form of descriptor (FN) | NO | |
| RxCUI: 1546377 | ramiprilat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546378 | rose bengal AT | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546379 | trandolaprilat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546380 | Gamma hydroxybutyric acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546380 | Gamma hydroxybutyric acid | Designated preferred name (PT) | YES | |
| RxCUI: 1546380 | Gamma hydroxybutyric acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1546380 | Gamma hydroxybutyric acid | Designated preferred name (PT) | YES | |
| RxCUI: 1546380 | Gamma hydroxybutyric acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546380 | Gamma hydroxybutyric acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1546381 | amaranth acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546382 | arsenite ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546384 | beclomethasone 17-monopropionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546386 | bromotheophylline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546387 | carbamoylcholine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546388 | cerous cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546390 | chlorate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546391 | chloric acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546392 | chlorite ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546393 | fosinoprilat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546394 | 131-I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546394 | 131-I | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546394 | 131-I | Designated preferred name (PT) | NO | |
| RxCUI: 1546394 | 131-I | Full form of descriptor (FN) | NO | |
| RxCUI: 1546394 | 131-I | Designated preferred name (PT) | NO | |
| RxCUI: 1546394 | 131-I | Full form of descriptor (FN) | NO | |
| RxCUI: 1546395 | molybdate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546396 | Olodaterol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546396 | Olodaterol hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 1546396 | Olodaterol hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 1546397 | sea snail preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546398 | selenite ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546399 | vecuronium cation | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546400 | perindoprilat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546402 | sulfonated oleic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546406 | Pamidronic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546406 | Pamidronic acid | Designated preferred name (PT) | YES | |
| RxCUI: 1546406 | Pamidronic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1546406 | Pamidronic acid | Designated preferred name (PT) | YES | |
| RxCUI: 1546406 | Pamidronic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1546408 | unoprostone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546409 | tripolyphosphate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546410 | Tiamulin | Full form of descriptor (FN) | NO | |
| RxCUI: 1546410 | Tiamulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546410 | Tiamulin | Designated preferred name (PT) | NO | |
| RxCUI: 1546410 | Tiamulin | Full form of descriptor (FN) | NO | |
| RxCUI: 1546410 | Tiamulin | Designated preferred name (PT) | NO | |
| RxCUI: 1546411 | thiosulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546412 | Gynochthodes officianalis root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546412 | Gynochthodes officianalis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546413 | methylhomatropine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546414 | methylene blue cation | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546415 | iodide ion I-131 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546416 | chlortheophylline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546417 | denatonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546418 | chromic cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546419 | cobaltous cation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546420 | condoliase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546421 | edrophonium cation | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546422 | epicriptine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546423 | ethyl salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546423 | ethyl salicylate | Designated preferred name (PT) | NO | |
| RxCUI: 1546423 | ethyl salicylate | Full form of descriptor (FN) | NO | |
| RxCUI: 1546424 | nitrite ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546425 | pyrophosphoric acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546425 | pyrophosphoric acid | Designated preferred name (PT) | NO | |
| RxCUI: 1546425 | pyrophosphoric acid | Full form of descriptor (FN) | NO | |
| RxCUI: 1546426 | laidlomycin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546427 | ethylmercurithiosalicylic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546428 | flunisolide anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546429 | gadolinium cation (3+) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 154643 | Mestranol- and norethisterone-containing product | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 154643 | Mestranol- and norethisterone-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 154643 | Mestranol- and norethisterone-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154643 | Mestranol- and norethisterone-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 1546431 | tetrachloroaurate ion | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546432 | Gadopentetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546432 | Gadopentetate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546433 | monomethyl fumarate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546433 | monomethyl fumarate | Designated preferred name (PT) | YES | |
| RxCUI: 1546433 | monomethyl fumarate | Full form of descriptor (FN) | YES | |
| RxCUI: 1546433 | monomethyl fumarate | Designated preferred name (PT) | YES | |
| RxCUI: 1546433 | monomethyl fumarate | Full form of descriptor (FN) | YES | |
| RxCUI: 1546434 | 82 rubidium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546435 | salmon gonadotropin releasing hormone D-Arg6 analog ethyl amide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546436 | polystyrene sulfonic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546437 | polystyrene sulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546437 | polystyrene sulfonate | Designated preferred name (PT) | NO | |
| RxCUI: 1546437 | polystyrene sulfonate | Full form of descriptor (FN) | NO | |
| RxCUI: 1546437 | polystyrene sulfonate | Designated preferred name (PT) | NO | |
| RxCUI: 1546437 | polystyrene sulfonate | Full form of descriptor (FN) | NO | |
| RxCUI: 1546438 | glycopyrronium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546438 | glycopyrronium | Designated preferred name (PT) | YES | |
| RxCUI: 1546438 | glycopyrronium | Full form of descriptor (FN) | YES | |
| RxCUI: 1546438 | glycopyrronium | Designated preferred name (PT) | YES | |
| RxCUI: 1546438 | glycopyrronium | Full form of descriptor (FN) | YES | |
| RxCUI: 1546439 | germanium cation (4+) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546440 | hypophosphite ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546441 | indigotindisulfonic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546442 | iodate ion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546443 | lanthanum cation (3+) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546444 | methylephedrine, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546445 | monofluorophosphate ion | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546446 | omacetaxine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546446 | omacetaxine | Designated preferred name (PT) | YES | |
| RxCUI: 1546446 | omacetaxine | Full form of descriptor (FN) | YES | |
| RxCUI: 1546447 | 4-phenylbutyric acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546447 | 4-phenylbutyric acid | Designated preferred name (PT) | YES | |
| RxCUI: 1546447 | 4-phenylbutyric acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1546447 | 4-phenylbutyric acid | Designated preferred name (PT) | YES | |
| RxCUI: 1546447 | 4-phenylbutyric acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1546448 | oxidronic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546449 | isoflupredone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546449 | isoflupredone | Designated preferred name (PT) | NO | |
| RxCUI: 1546449 | isoflupredone | Full form of descriptor (FN) | NO | |
| RxCUI: 1546450 | radium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546451 | iotalamic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546451 | iotalamic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546451 | iotalamic acid | Designated preferred name (PT) | YES | |
| RxCUI: 1546451 | iotalamic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1546451 | iotalamic acid | Designated preferred name (PT) | YES | |
| RxCUI: 1546451 | iotalamic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 1546452 | iothalamic acid I-125 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546453 | isosulfan blue inner salt | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546454 | valeric acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546455 | Hypericin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546455 | Hypericin | Designated preferred name (PT) | NO | |
| RxCUI: 1546455 | Hypericin | Full form of descriptor (FN) | NO | |
| RxCUI: 1546457 | picosulfuric acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1546458 | picosulfurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546541 | racemethionine Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1546542 | racemethionine Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1546543 | racemethionine 500 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546543 | racemethionine 500 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546544 | Methio-Form | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1546545 | racemethionine 500 MG [Methio-Form] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1546546 | racemethionine Chewable Tablet [Methio-Form] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1546547 | Methio-Form Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1546548 | Methio-Form Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1546549 | Methio-Form Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1546550 | Methio-Form 500 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546550 | Methio-Form 500 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546550 | Methio-Form 500 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546588 | salicylic acid 2 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546588 | salicylic acid 2 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546588 | salicylic acid 2 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546589 | zinc oxide 14 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546589 | zinc oxide 14 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546589 | zinc oxide 14 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546589 | zinc oxide 14 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546595 | PACLitaxel 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1546595 | PACLitaxel 1 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1546596 | PACLitaxel 1 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546596 | PACLitaxel 1 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1546597 | Paccal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1546598 | PACLitaxel 1 MG/ML [Paccal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1546598 | PACLitaxel 1 MG/ML [Paccal] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1546599 | PACLitaxel Injectable Solution [Paccal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1546599 | PACLitaxel Injectable Solution [Paccal] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1546600 | Paccal Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1546601 | paclitaxel 1 MG/ML Injectable Solution [Paccal] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546601 | paclitaxel 1 MG/ML Injectable Solution [Paccal] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546601 | paclitaxel 1 MG/ML Injectable Solution [Paccal] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546601 | paclitaxel 1 MG/ML Injectable Solution [Paccal] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1546700 | acetaminophen 325 MG / dexbrompheniramine maleate 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546700 | acetaminophen 325 MG / dexbrompheniramine maleate 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1546700 | acetaminophen 325 MG / dexbrompheniramine maleate 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546703 | histamine dihydrochloride 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1546704 | histamine Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1546705 | histamine diHCl 0.06 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546705 | histamine diHCl 0.06 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546705 | histamine diHCl 0.06 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546706 | Pandanus tectorius root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546707 | Usnic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 1546707 | Usnic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546707 | Usnic acid | Designated preferred name (PT) | NO | |
| RxCUI: 1546707 | Usnic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 1546707 | Usnic acid | Designated preferred name (PT) | NO | |
| RxCUI: 1546708 | disteareth-75 isophorone diisocyanate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 154682 | Hyalgan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1546861 | Acmella oleracea whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546862 | Adonis vernalis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546863 | Artemisia tridentata top oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546864 | Cynanchum paniculatum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546865 | Sparganium stoloniferum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546866 | Tinospora capillipes root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546867 | Entada phaseoloides whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546868 | Bos taurus mammary gland preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546869 | Sus scrofa ligament preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1546870 | ceteareth-10 phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1546871 | Sodium clodronate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1546871 | Sodium clodronate | Designated preferred name (PT) | YES | |
| RxCUI: 1546871 | Sodium clodronate | Full form of descriptor (FN) | YES | |
| RxCUI: 1546871 | Sodium clodronate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546875 | acetaminophen / dextromethorphan / doxylamine / phenylephrine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1546881 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546881 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1546881 | acetaminophen 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine HCl 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546884 | abacavir / dolutegravir / lamiVUDine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1546884 | abacavir / dolutegravir / lamiVUDine Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1546884 | abacavir / dolutegravir / lamiVUDine Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1546884 | abacavir / dolutegravir / lamiVUDine Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1546885 | abacavir / dolutegravir / lamiVUDine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1546885 | abacavir / dolutegravir / lamiVUDine Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1546886 | abacavir / dolutegravir / lamiVUDine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1546886 | abacavir / dolutegravir / lamiVUDine Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1546887 | abacavir / dolutegravir / lamiVUDine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1546887 | abacavir / dolutegravir / lamiVUDine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1546887 | abacavir / dolutegravir / lamiVUDine | Designated preferred name (PT) | YES | |
| RxCUI: 1546887 | abacavir / dolutegravir / lamiVUDine | Full form of descriptor (FN) | YES | |
| RxCUI: 1546888 | abacavir 600 MG / dolutegravir 50 MG / lamiVUDine 300 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1546888 | abacavir 600 MG / dolutegravir 50 MG / lamiVUDine 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546888 | abacavir 600 MG / dolutegravir 50 MG / lamiVUDine 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546888 | abacavir 600 MG / dolutegravir 50 MG / lamiVUDine 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1546888 | abacavir 600 MG / dolutegravir 50 MG / lamiVUDine 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1546888 | abacavir 600 MG / dolutegravir 50 MG / lamiVUDine 300 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1546889 | Triumeq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1546890 | abacavir 600 MG / dolutegravir 50 MG / lamiVUDine 300 MG [Triumeq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1546890 | abacavir 600 MG / dolutegravir 50 MG / lamiVUDine 300 MG [Triumeq] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1546891 | abacavir / dolutegravir / lamiVUDine Oral Tablet [Triumeq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1546891 | abacavir / dolutegravir / lamiVUDine Oral Tablet [Triumeq] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1546892 | Triumeq Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1546893 | Triumeq Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1546894 | Triumeq 600 MG / 50 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546894 | Triumeq 600 MG / 50 MG / 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1546894 | Triumeq 600 MG / 50 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1546894 | Triumeq 600 MG / 50 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1546894 | Triumeq 600 MG / 50 MG / 300 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1546894 | Triumeq 600 MG / 50 MG / 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1546895 | trolamine salicylate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1546896 | trolamine salicylate 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546896 | trolamine salicylate 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546896 | trolamine salicylate 10 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546897 | menthol 0.022 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1546898 | camphor 3 % / menthol 2.2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1546898 | camphor 3 % / menthol 2.2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546898 | camphor 3 % / menthol 2.2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1546899 | One Gel Sport | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1546900 | camphor 0.03 MG/MG / menthol 0.022 MG/MG [One Gel Sport] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1546901 | camphor / menthol Topical Gel [One Gel Sport] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1546902 | One Gel Sport Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1546903 | One Gel Sport ( 3 % / 2.2 % ) Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1546903 | One Gel Sport ( 3 % / 2.2 % ) Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1546903 | One Gel Sport ( 3 % / 2.2 % ) Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154708 | Substance with N-methyl-D-aspartate receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 154708 | Substance with N-methyl-D-aspartate receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 154708 | Substance with N-methyl-D-aspartate receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 154708 | Substance with N-methyl-D-aspartate receptor antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154708 | Substance with N-methyl-D-aspartate receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1547099 | suvorexant | Full form of descriptor (FN) | YES | |
| RxCUI: 1547099 | suvorexant | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1547099 | suvorexant | Designated preferred name (PT) | YES | |
| RxCUI: 1547099 | suvorexant | Full form of descriptor (FN) | YES | |
| RxCUI: 1547099 | suvorexant | Designated preferred name (PT) | YES | |
| RxCUI: 1547100 | suvorexant 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547101 | suvorexant Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1547101 | suvorexant Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1547101 | suvorexant Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1547102 | suvorexant Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1547103 | suvorexant Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1547104 | suvorexant 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547104 | suvorexant 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547105 | Belsomra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1547106 | suvorexant 10 MG [Belsomra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547107 | suvorexant Oral Tablet [Belsomra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1547108 | Belsomra Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1547109 | Belsomra Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1547110 | Belsomra 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547110 | Belsomra 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547110 | Belsomra 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547111 | suvorexant 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547112 | suvorexant 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547112 | suvorexant 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547113 | suvorexant 15 MG [Belsomra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547114 | Belsomra 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547114 | Belsomra 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547114 | Belsomra 15 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547115 | suvorexant 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547116 | suvorexant 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547116 | suvorexant 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547117 | suvorexant 20 MG [Belsomra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547118 | Belsomra 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547118 | Belsomra 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547118 | Belsomra 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547120 | povidone-iodine 100 MG/ML [Triadine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547121 | TRIADINE Whirlpool Concentrate 10 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547121 | TRIADINE Whirlpool Concentrate 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547121 | TRIADINE Whirlpool Concentrate 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547121 | TRIADINE Whirlpool Concentrate 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547214 | Remain Gold | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1547215 | bronopol 2 MG/ML [Remain Gold] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547216 | bronopol Topical Solution [Remain Gold] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1547217 | Remain Gold Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1547218 | Remain Gold 0.2 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547218 | Remain Gold 0.2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547218 | Remain Gold 0.2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547218 | Remain Gold 0.2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547219 | eliglustat tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1547219 | eliglustat tartrate | Designated preferred name (PT) | NO | |
| RxCUI: 1547219 | eliglustat tartrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1547220 | eliglustat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1547220 | eliglustat | Designated preferred name (PT) | YES | |
| RxCUI: 1547220 | eliglustat | Full form of descriptor (FN) | YES | |
| RxCUI: 1547220 | eliglustat | Designated preferred name (PT) | YES | |
| RxCUI: 1547220 | eliglustat | Full form of descriptor (FN) | YES | |
| RxCUI: 1547221 | eliglustat 84 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547222 | eliglustat Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1547222 | eliglustat Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1547222 | eliglustat Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1547223 | eliglustat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1547224 | eliglustat Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1547225 | eliglustat 84 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 1547225 | eliglustat 84 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547225 | eliglustat 84 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547225 | eliglustat 84 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547225 | eliglustat 84 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 1547226 | Cerdelga | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1547227 | eliglustat 84 MG [Cerdelga] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547228 | eliglustat Oral Capsule [Cerdelga] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1547229 | Cerdelga Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1547230 | Cerdelga Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1547231 | Cerdelga 84 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547231 | Cerdelga 84 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547231 | Cerdelga 84 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547231 | Cerdelga 84 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547232 | Product containing sodium bicarbonate in cutaneous dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 1547232 | Product containing sodium bicarbonate in cutaneous dose form (medicinal product form) | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1547232 | Product containing sodium bicarbonate in cutaneous dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 1547233 | sodium bicarbonate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1547234 | sodium bicarbonate 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547234 | sodium bicarbonate 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547234 | sodium bicarbonate 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547234 | sodium bicarbonate 5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547240 | Run Guard | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1547241 | allantoin 0.005 MG/MG [Run Guard] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547242 | allantoin Topical Ointment [Run Guard] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1547243 | Run Guard Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1547244 | Run Guard 0.5 % Topical Stick | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547244 | Run Guard 0.5 % Topical Stick | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547244 | Run Guard 0.5 % Topical Stick | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547436 | calcium acetate 22 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547437 | magnesium acetate 43 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547438 | potassium acetate 34.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547439 | potassium chloride 125 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547440 | sodium acetate 135 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547441 | sodium gluconate 55 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547442 | calcium acetate / magnesium acetate / potassium acetate / potassium chloride / sodium acetate / sodium gluconate Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1547443 | calcium acetate / magnesium acetate / potassium acetate / potassium chloride / sodium acetate / sodium gluconate Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1547444 | calcium acetate / magnesium acetate / potassium acetate / potassium chloride / sodium acetate / sodium gluconate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1547445 | calcium acetate 22 MG/ML / magnesium acetate 43 MG/ML / K+ Acetate 34.5 MG/ML / K+ Chloride 125 MG/ML / Sodium Acetate 135 MG/ML / Sodium gluconate 55 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547445 | calcium acetate 22 MG/ML / magnesium acetate 43 MG/ML / K+ Acetate 34.5 MG/ML / K+ Chloride 125 MG/ML / Sodium Acetate 135 MG/ML / Sodium gluconate 55 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547445 | calcium acetate 22 MG/ML / magnesium acetate 43 MG/ML / K+ Acetate 34.5 MG/ML / K+ Chloride 125 MG/ML / Sodium Acetate 135 MG/ML / Sodium gluconate 55 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547446 | Nutrilyte | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1547447 | calcium acetate 22 MG/ML / magnesium acetate 43 MG/ML / potassium acetate 34.5 MG/ML / potassium chloride 125 MG/ML / sodium acetate 135 MG/ML / sodium gluconate 55 MG/ML [Nutrilyte] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547448 | calcium acetate / magnesium acetate / potassium acetate / potassium chloride / sodium acetate / sodium gluconate Injectable Solution [Nutrilyte] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1547449 | Nutrilyte Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1547450 | NUTRILYTE Concentrated Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547450 | NUTRILYTE Concentrated Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547450 | NUTRILYTE Concentrated Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547450 | NUTRILYTE Concentrated Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547451 | calcium chloride 16.55 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547452 | magnesium chloride 25.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547453 | potassium acetate 98 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547454 | sodium acetate 64.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547455 | sodium chloride 74.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547456 | calcium chloride / magnesium chloride / potassium acetate / sodium acetate / sodium chloride Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1547457 | calcium chloride / magnesium chloride / potassium acetate / sodium acetate / sodium chloride Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1547458 | calcium chloride / magnesium chloride / potassium acetate / sodium acetate / sodium chloride | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1547459 | Calcium Chloride 16.55 MG/ML / Magnesium Chloride 25.5 MG/ML / Pot Acetate 98 MG/ML / Sodium Acetate 64.6 MG/ML / NaCl 74.5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547459 | Calcium Chloride 16.55 MG/ML / Magnesium Chloride 25.5 MG/ML / Pot Acetate 98 MG/ML / Sodium Acetate 64.6 MG/ML / NaCl 74.5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547459 | Calcium Chloride 16.55 MG/ML / Magnesium Chloride 25.5 MG/ML / Pot Acetate 98 MG/ML / Sodium Acetate 64.6 MG/ML / NaCl 74.5 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547460 | Nutrilyte II | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1547461 | calcium chloride 16.55 MG/ML / magnesium chloride 25.5 MG/ML / potassium acetate 98 MG/ML / sodium acetate 64.6 MG/ML / sodium chloride 74.5 MG/ML [Nutrilyte II] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547462 | calcium chloride / magnesium chloride / potassium acetate / sodium acetate / sodium chloride Injectable Solution [Nutrilyte II] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1547463 | Nutrilyte II Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1547464 | calcium chloride 16.55 MG/ML / magnesium chloride 25.5 MG/ML / potassium acetate 98 MG/ML / sodium acetate 64.6 MG/ML / sodium chloride 74.5 MG/ML Injectable Solution [Nutrilyte II] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547464 | calcium chloride 16.55 MG/ML / magnesium chloride 25.5 MG/ML / potassium acetate 98 MG/ML / sodium acetate 64.6 MG/ML / sodium chloride 74.5 MG/ML Injectable Solution [Nutrilyte II] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547464 | calcium chloride 16.55 MG/ML / magnesium chloride 25.5 MG/ML / potassium acetate 98 MG/ML / sodium acetate 64.6 MG/ML / sodium chloride 74.5 MG/ML Injectable Solution [Nutrilyte II] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547465 | Senegalia catechu bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547465 | Senegalia catechu bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547466 | Agrimonia pilosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547467 | Artemisia princeps leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547468 | Rubia cordifolia root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1547469 | Sparganium stoloniferium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547470 | Brucea javanica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547471 | Celosia cristata flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547472 | Corydalis bungeana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547545 | pembrolizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1547545 | pembrolizumab | Designated preferred name (PT) | YES | |
| RxCUI: 1547545 | pembrolizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 1547545 | pembrolizumab | Designated preferred name (PT) | YES | |
| RxCUI: 1547545 | pembrolizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 1547546 | pembrolizumab 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547547 | pembrolizumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1547547 | pembrolizumab Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 1547547 | pembrolizumab Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1547550 | Keytruda | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1547551 | pembrolizumab 25 MG/ML [Keytruda] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547553 | Keytruda Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1547555 | Cytisus scoparius flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547556 | Sphaeranthus indicus flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547557 | threonic acid, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1547558 | threonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547559 | Gentiana manshurica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547560 | ISOtretinoin 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547560 | ISOtretinoin 25 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1547561 | ISOtretinoin 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547561 | ISOtretinoin 25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547561 | ISOtretinoin 25 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1547562 | ISOtretinoin 25 MG [Absorica] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547562 | ISOtretinoin 25 MG [Absorica] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1547563 | Absorica 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547563 | Absorica 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547563 | Absorica 25 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547563 | Absorica 25 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1547564 | ISOtretinoin 35 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547564 | ISOtretinoin 35 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1547565 | ISOtretinoin 35 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547565 | ISOtretinoin 35 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547565 | ISOtretinoin 35 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1547566 | ISOtretinoin 35 MG [Absorica] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547566 | ISOtretinoin 35 MG [Absorica] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1547567 | Absorica 35 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547567 | Absorica 35 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547567 | Absorica 35 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547567 | Absorica 35 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1547568 | Borago officinialis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547569 | Brassica juncea seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547570 | peach kernel oil glycereth-8 esters | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547571 | Piellia ternata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547572 | suvorexant 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547573 | suvorexant 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547573 | suvorexant 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547574 | suvorexant 5 MG [Belsomra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547575 | Belsomra 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547575 | Belsomra 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547575 | Belsomra 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547577 | Lactarius indigo whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547578 | Curcuma amada whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547579 | Streptococcus pneumoniae type 1 capsular polysaccharide antigen / Streptococcus pneumoniae type 10A capsular polysaccharide antigen / Streptococcus pneumoniae type 11A capsular polysaccharide antigen / Streptococcus pneumoniae type 12F capsular polysaccharide antigen / Streptococcus pneumoniae type 14 capsular polysaccharide antigen / Streptococcus pneumoniae type 15B capsular polysaccharide antigen / Streptococcus pneumoniae type 17F capsular polysaccharide antigen / Streptococcus pneumoniae type 18C capsular polysaccharide antigen / Streptococcus pneumoniae type 19A capsular polysaccharide antigen / Streptococcus pneumoniae type 19F capsular polysaccharide antigen / Streptococcus pneumoniae type 2 capsular polysaccharide antigen / Streptococcus pneumoniae type 20 capsular polysaccharide antigen / Streptococcus pneumoniae type 22F capsular polysaccharide antigen / Streptococcus pneumoniae type 23F capsular polysaccharide antigen / Streptococcus pneumoniae type 3 capsular polysaccharide antigen / Streptococcus pneumoniae type 33F capsular polysaccharide antigen / Streptococcus pneumoniae type 4 capsular polysaccharide antigen / Streptococcus pneumoniae type 5 capsular polysaccharide antigen / Streptococcus pneumoniae type 6B capsular polysaccharide antigen / Streptococcus pneumoniae type 7F capsular polysaccharide antigen / Streptococcus pneumoniae type 8 capsular polysaccharide antigen / Streptococcus pneumoniae type 9N capsular polysaccharide antigen / Streptococcus pneumoniae type 9V capsular polysaccharide antigen Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1547580 | pneumococcal 23-valent polysaccharide vaccine (PPSV23) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547580 | pneumococcal 23-valent polysaccharide vaccine (PPSV23) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547580 | pneumococcal 23-valent polysaccharide vaccine (PPSV23) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547581 | Streptococcus pneumoniae type 1 capsular polysaccharide antigen / Streptococcus pneumoniae type 10A capsular polysaccharide antigen / Streptococcus pneumoniae type 11A capsular polysaccharide antigen / Streptococcus pneumoniae type 12F capsular polysaccharide antigen / Streptococcus pneumoniae type 14 capsular polysaccharide antigen / Streptococcus pneumoniae type 15B capsular polysaccharide antigen / Streptococcus pneumoniae type 17F capsular polysaccharide antigen / Streptococcus pneumoniae type 18C capsular polysaccharide antigen / Streptococcus pneumoniae type 19A capsular polysaccharide antigen / Streptococcus pneumoniae type 19F capsular polysaccharide antigen / Streptococcus pneumoniae type 2 capsular polysaccharide antigen / Streptococcus pneumoniae type 20 capsular polysaccharide antigen / Streptococcus pneumoniae type 22F capsular polysaccharide antigen / Streptococcus pneumoniae type 23F capsular polysaccharide antigen / Streptococcus pneumoniae type 3 capsular polysaccharide antigen / Streptococcus pneumoniae type 33F capsular polysaccharide antigen / Streptococcus pneumoniae type 4 capsular polysaccharide antigen / Streptococcus pneumoniae type 5 capsular polysaccharide antigen / Streptococcus pneumoniae type 6B capsular polysaccharide antigen / Streptococcus pneumoniae type 7F capsular polysaccharide antigen / Streptococcus pneumoniae type 8 capsular polysaccharide antigen / Streptococcus pneumoniae type 9N capsular polysaccharide antigen / Streptococcus pneumoniae type 9V capsular polysaccharide antigen Prefilled Syringe [Pneumovax 23] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1547582 | PNEUMOVAX 23 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547582 | PNEUMOVAX 23 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547582 | PNEUMOVAX 23 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547583 | Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 12F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 14 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 15B capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 17F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 18C capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 19A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 19F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 2 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 20 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 22F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 23F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 3 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 33F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 4 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 5 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 6B capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 7F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 8 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 9N capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 9V capsular polysaccharide antigen 0.05 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547584 | Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 12F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 14 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 15B capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 17F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 18C capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 19A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 19F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 2 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 20 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 22F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 23F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 3 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 33F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 4 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 5 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 6B capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 7F capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 8 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 9N capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 9V capsular polysaccharide antigen 0.05 MG/ML Prefilled Syringe [Pneumovax 23] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547587 | benzocaine 18 % / tetracaine HCl 2 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547587 | benzocaine 18 % / tetracaine HCl 2 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547587 | benzocaine 18 % / tetracaine HCl 2 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547588 | benzocaine 0.18 MG/MG / tetracaine hydrochloride 0.02 MG/MG [DentiCare Denti Freeze Gel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547589 | Denti-Care Denti-Freeze 18 % / 2 % Oral Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547589 | Denti-Care Denti-Freeze 18 % / 2 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547589 | Denti-Care Denti-Freeze 18 % / 2 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547590 | benzocaine 0.09 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1547591 | benzocaine 9 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547591 | benzocaine 9 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547591 | benzocaine 9 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547592 | benzocaine 0.09 MG/MG [Brace Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547593 | Brace Relief 9 % Oral Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547593 | Brace Relief 9 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547593 | Brace Relief 9 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547593 | Brace Relief 9 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547606 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / pseudoephedrine hydrochloride 6 MG/ML [Lortuss EX] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547606 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML / pseudoephedrine hydrochloride 6 MG/ML [Lortuss EX] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1547607 | Lortuss EX 10 MG / 100 MG / 30 MG in 5 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547607 | Lortuss EX 10 MG / 100 MG / 30 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1547607 | Lortuss EX 10 MG / 100 MG / 30 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547607 | Lortuss EX 10 MG / 100 MG / 30 MG in 5 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1547607 | Lortuss EX 10 MG / 100 MG / 30 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547608 | Euphorbia amygdaloides extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547609 | morrhuic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1547610 | morrhuate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547611 | oritavancin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1547611 | oritavancin | Designated preferred name (PT) | YES | |
| RxCUI: 1547611 | oritavancin | Full form of descriptor (FN) | YES | |
| RxCUI: 1547611 | oritavancin | Designated preferred name (PT) | YES | |
| RxCUI: 1547611 | oritavancin | Full form of descriptor (FN) | YES | |
| RxCUI: 1547613 | oritavancin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1547615 | oritavancin 400 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547615 | oritavancin 400 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547615 | oritavancin 400 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547616 | Orbactiv | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1547619 | Orbactiv Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 154762 | Conceptrol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1547620 | Orbactiv 400 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547620 | Orbactiv 400 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547620 | Orbactiv 400 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547620 | Orbactiv 400 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547621 | Pseudolarix amabilis bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1547622 | PEG-32 hydrogenated palm glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1547623 | chrysanthemin extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547630 | osthol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1547632 | sodium diacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547633 | sulfur 66 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1547634 | sulfur 6.6 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547634 | sulfur 6.6 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547634 | sulfur 6.6 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547635 | Rea Lo 39 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1547636 | urea 390 MG/ML [Rea Lo 39] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547637 | urea Topical Cream [Rea Lo 39] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1547638 | Rea Lo 39 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1547639 | Rea Lo 39 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547639 | Rea Lo 39 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547639 | Rea Lo 39 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547639 | Rea Lo 39 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547641 | salicylic acid 19 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547642 | salicylic acid 1.9 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547642 | salicylic acid 1.9 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547642 | salicylic acid 1.9 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547643 | Clearasil Ultra 5 in 1 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1547644 | salicylic acid 19 MG/ML [Clearasil Ultra 5 in 1] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547645 | salicylic acid Medicated Pad [Clearasil Ultra 5 in 1] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1547646 | Clearasil Ultra 5 in 1 Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1547647 | Clearasil Ultra 5 in 1 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1547648 | Clearasil Ultra 5-in-1 1.9 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547648 | Clearasil Ultra 5-in-1 1.9 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547648 | Clearasil Ultra 5-in-1 1.9 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547648 | Clearasil Ultra 5-in-1 1.9 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547650 | Arnuity | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1547652 | fluticasone Dry Powder Inhaler [Arnuity] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1547653 | Arnuity Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1547658 | fluticasone furoate 100 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547658 | fluticasone furoate 100 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547658 | fluticasone furoate 100 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547659 | fluticasone furoate 0.1 MG/ACTUAT [Arnuity] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547660 | ARNUITY ELLIPTA 100 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547660 | ARNUITY ELLIPTA 100 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547660 | ARNUITY ELLIPTA 100 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547661 | fluticasone furoate 0.1 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547662 | fluticasone furoate 0.1 MG/ACTUAT Dry Powder Inhaler [Arnuity] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547663 | fluticasone furoate 100 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547663 | fluticasone furoate 100 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547663 | fluticasone furoate 100 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547664 | ARNUITY ELLIPTA 100 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547664 | ARNUITY ELLIPTA 100 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547664 | ARNUITY ELLIPTA 100 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547664 | ARNUITY ELLIPTA 100 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547665 | fluticasone furoate 0.2 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547666 | fluticasone furoate 200 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547666 | fluticasone furoate 200 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547666 | fluticasone furoate 200 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547667 | fluticasone furoate 0.2 MG/ACTUAT [Arnuity] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547668 | ARNUITY ELLIPTA 200 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547668 | ARNUITY ELLIPTA 200 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547668 | ARNUITY ELLIPTA 200 MCG/INHAL Dry Powder Inhaler, 14 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547669 | fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547670 | fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler [Arnuity] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547670 | fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler [Arnuity] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547671 | fluticasone furoate 200 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547671 | fluticasone furoate 200 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547671 | fluticasone furoate 200 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547672 | ARNUITY ELLIPTA 200 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547672 | ARNUITY ELLIPTA 200 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547672 | ARNUITY ELLIPTA 200 MCG/INHAL Dry Powder Inhaler, 30 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 15477 | 5'-methylthioadenosine phosphorylase | Designated preferred name (PT) | NO | |
| RxCUI: 15477 | 5'-methylthioadenosine phosphorylase | Full form of descriptor (FN) | NO | |
| RxCUI: 1547708 | carbamide peroxide 10 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547708 | carbamide peroxide 10 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547708 | carbamide peroxide 10 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547708 | carbamide peroxide 10 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547711 | DEBACTEROL 50 % / 30 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547711 | DEBACTEROL 50 % / 30 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547711 | DEBACTEROL 50 % / 30 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547711 | DEBACTEROL 50 % / 30 % Mucous Membrane Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547712 | Acmella oleracea flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547713 | C12-15 alkyl ethylhexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547736 | detomidine hydrochloride 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1547737 | detomidine HCl 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547737 | detomidine HCl 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547737 | detomidine HCl 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547738 | detomidine hydrochloride 10 MG/ML [DORMOSEDAN] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547739 | detomidine Injectable Solution [DORMOSEDAN] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1547740 | DORMOSEDAN Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1547741 | detomidine hydrochloride 10 MG/ML Injectable Solution [DORMOSEDAN] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547741 | detomidine hydrochloride 10 MG/ML Injectable Solution [DORMOSEDAN] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547742 | Isothesia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1547743 | isoflurane 999 MG/ML [Isothesia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547745 | Isothesia Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1547746 | IsoThesia 99.9 % Inhalation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547746 | IsoThesia 99.9 % Inhalation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547746 | IsoThesia 99.9 % Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547755 | Stephania tetrandra root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1547756 | menthol 0.023 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1547757 | methyl salicylate 0.146 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1547758 | camphor 3.5 % / menthol 2.3 % / methyl salicylate 14.6 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547758 | camphor 3.5 % / menthol 2.3 % / methyl salicylate 14.6 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547758 | camphor 3.5 % / menthol 2.3 % / methyl salicylate 14.6 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547764 | benzocaine / cetylpyridinium / menthol Mucous Membrane Topical Solution [Orasep Reformulated Dec 2013] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1547767 | Orasep (2 % / 0.1 % / 0.5 % ) Mucous Membrane Topical Solution, Reformulated Dec 2013 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547767 | Orasep (2 % / 0.1 % / 0.5 % ) Mucous Membrane Topical Solution, Reformulated Dec 2013 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547767 | Orasep (2 % / 0.1 % / 0.5 % ) Mucous Membrane Topical Solution, Reformulated Dec 2013 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547770 | malachite green cation | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1547771 | tetracaine HCl 0.5 % Ophthalmic Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 1547771 | tetracaine HCl 0.5 % Ophthalmic Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 1547771 | tetracaine HCl 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547771 | tetracaine HCl 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547771 | tetracaine HCl 0.5 % Ophthalmic Solution | Designated preferred name (PT) | YES | |
| RxCUI: 1547771 | tetracaine HCl 0.5 % Ophthalmic Solution | Designated preferred name (PT) | YES | |
| RxCUI: 1547771 | tetracaine HCl 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547772 | tetracaine hydrochloride 5 MG/ML [Altacaine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547773 | ALTACAINE 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547773 | ALTACAINE 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547773 | ALTACAINE 0.5 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547774 | tetracaine hydrochloride 5 MG/ML [Tetcaine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547775 | Tetcaine 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547775 | Tetcaine 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547775 | Tetcaine 0.5 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547776 | tetracaine hydrochloride 5 MG/ML [Tetravisc] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1547777 | TetraVisc 0.5 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1547777 | TetraVisc 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547777 | TetraVisc 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547777 | TetraVisc 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547926 | phenylephrine 1.2 MG/mL Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547926 | phenylephrine 1.2 MG/mL Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547926 | phenylephrine 1.2 MG/mL Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547927 | phenylephrine hydrochloride 1.2 MG/ML [Prefrin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547928 | Prefrin 0.12 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547928 | Prefrin 0.12 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547928 | Prefrin 0.12 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547936 | antipyrine 0.1 % / phenylephrine HCl 0.12 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547936 | antipyrine 0.1 % / phenylephrine HCl 0.12 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547936 | antipyrine 0.1 % / phenylephrine HCl 0.12 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547937 | phenylephrine hydrochloride 1.2 MG/ML [Isopto Frin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547938 | Isopto Frin 0.12 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547938 | Isopto Frin 0.12 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547938 | Isopto Frin 0.12 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547939 | carboxymethylcellulose sodium 7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547940 | carboxymethylcellulose sodium 0.7 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547940 | carboxymethylcellulose sodium 0.7 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547940 | carboxymethylcellulose sodium 0.7 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547941 | Urin DS | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1547942 | hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG [Urin DS] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547944 | Urin DS Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1547945 | Urin DS Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1547947 | carboxymethylcellulose sodium 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547948 | carboxymethylcellulose sodium 0.25 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547948 | carboxymethylcellulose sodium 0.25 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547948 | carboxymethylcellulose sodium 0.25 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547951 | hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet [Urin DS] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1547952 | hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urin DS] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547952 | hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urin DS] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547954 | clotrimazole 1 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547954 | clotrimazole 1 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547954 | clotrimazole 1 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547972 | polyvinyl alcohol 0.03 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1547973 | polyvinyl alcohol 3 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547973 | polyvinyl alcohol 3 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547973 | polyvinyl alcohol 3 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547974 | prednisoLONE sodium phosphate 0.5 % Ophthalmic Solution | Designated preferred name (PT) | NO | |
| RxCUI: 1547974 | prednisoLONE sodium phosphate 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547974 | prednisoLONE sodium phosphate 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547974 | prednisoLONE sodium phosphate 0.5 % Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1547974 | prednisoLONE sodium phosphate 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547974 | prednisoLONE sodium phosphate 0.5 % Ophthalmic Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1547974 | prednisoLONE sodium phosphate 0.5 % Ophthalmic Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 1547975 | tetracaine HCl 2 % Ophthalmic Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 1547975 | tetracaine HCl 2 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547975 | tetracaine HCl 2 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547975 | tetracaine HCl 2 % Ophthalmic Solution | Designated preferred name (PT) | NO | |
| RxCUI: 1547975 | tetracaine HCl 2 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547976 | tetracaine hydrochloride 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1547977 | tetracaine HCl 1 % Ophthalmic Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 1547977 | tetracaine HCl 1 % Ophthalmic Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 1547977 | tetracaine HCl 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547977 | tetracaine HCl 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547977 | tetracaine HCl 1 % Ophthalmic Solution | Designated preferred name (PT) | NO | |
| RxCUI: 1547977 | tetracaine HCl 1 % Ophthalmic Solution | Designated preferred name (PT) | NO | |
| RxCUI: 1547977 | tetracaine HCl 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547978 | tetracaine hydrochloride 10 MG/ML [Minims Amethocaine hydrochloride] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547979 | Minims Amethocaine HCl 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547979 | Minims Amethocaine HCl 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547979 | Minims Amethocaine HCl 1 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547980 | scopolamine hydrobromide 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1547981 | phenylephrine HCl 10 % / scopolamine HBr 0.3 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547981 | phenylephrine HCl 10 % / scopolamine HBr 0.3 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547981 | phenylephrine HCl 10 % / scopolamine HBr 0.3 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1547982 | phenylephrine hydrochloride 100 MG/ML / scopolamine hydrobromide 3 MG/ML [Murocoll 2] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547983 | Murocoll 2 10 % / 0.3 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547983 | Murocoll 2 10 % / 0.3 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1547983 | Murocoll 2 10 % / 0.3 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547986 | Max Lax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1547987 | magnesium citrate 58.2 MG/ML [Max Lax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547988 | magnesium citrate Oral Solution [Max Lax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1547989 | Max Lax Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1547990 | Max Lax Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1547991 | magnesium citrate 58.2 MG/ML Oral Solution [Max Lax] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547991 | magnesium citrate 58.2 MG/ML Oral Solution [Max Lax] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547992 | camphor 4.8 % / eucalyptus oil 1.2 % / menthol 2.6 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1547992 | camphor 4.8 % / eucalyptus oil 1.2 % / menthol 2.6 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1547992 | camphor 4.8 % / eucalyptus oil 1.2 % / menthol 2.6 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1547993 | Clindrops | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1547994 | clindamycin 25 MG/ML [Clindrops] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1547995 | clindamycin Oral Solution [Clindrops] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1547996 | Clindrops Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1547997 | Clindrops Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1547998 | clindamycin 25 MG/ML Oral Solution [Clindrops] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1547998 | clindamycin 25 MG/ML Oral Solution [Clindrops] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1547998 | clindamycin 25 MG/ML Oral Solution [Clindrops] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154826 | Benzpyrinium | Designated preferred name (PT) | NO | |
| RxCUI: 154826 | Benzpyrinium | Full form of descriptor (FN) | NO | |
| RxCUI: 1548671 | carboxymethylcellulose sodium 0.5 % / glycerin 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1548671 | carboxymethylcellulose sodium 0.5 % / glycerin 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1548671 | carboxymethylcellulose sodium 0.5 % / glycerin 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1548672 | phenylephrine hydrochloride 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1548673 | phenylephrine HCl 5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1548673 | phenylephrine HCl 5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1548673 | phenylephrine HCl 5 % Ophthalmic Solution | Designated preferred name (PT) | NO | |
| RxCUI: 1548673 | phenylephrine HCl 5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1548673 | phenylephrine HCl 5 % Ophthalmic Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 1548704 | prednisolone acetate 10 MG/ML [Econopred Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1548704 | prednisolone acetate 10 MG/ML [Econopred Plus] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1548705 | Econopred Plus 1 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1548705 | Econopred Plus 1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1548705 | Econopred Plus 1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1548705 | Econopred Plus 1 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1548705 | Econopred Plus 1 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1548713 | prednisolone acetate 10 MG/ML [Omnipred] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1548713 | prednisolone acetate 10 MG/ML [Omnipred] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1548714 | Omnipred 1 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1548714 | Omnipred 1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1548714 | Omnipred 1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1548714 | Omnipred 1 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1548714 | Omnipred 1 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1548723 | prednisolone acetate 10 MG/ML [Pred Forte] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1548723 | prednisolone acetate 10 MG/ML [Pred Forte] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1548724 | Pred Forte 1 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1548724 | Pred Forte 1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1548724 | Pred Forte 1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1548724 | Pred Forte 1 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1548724 | Pred Forte 1 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1548738 | prednisolone acetate 10 MG/ML [Ocu-Pred-A] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1548738 | prednisolone acetate 10 MG/ML [Ocu-Pred-A] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1548739 | Ocu-Pred-A 1 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1548739 | Ocu-Pred-A 1 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1548739 | Ocu-Pred-A 1 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1548739 | Ocu-Pred-A 1 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 154876 | thiophene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1548868 | benzoyl peroxide 25 MG/ML [Acnefree BP] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1548869 | benzoyl peroxide Topical Cream [Acnefree BP] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1548870 | AcneFree BP 2.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1548870 | AcneFree BP 2.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1548870 | AcneFree BP 2.5 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1548871 | benzoyl peroxide 3 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1548871 | benzoyl peroxide 3 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1548872 | benzoyl peroxide 30 MG/ML [Acnefree BP] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1548873 | Acnefree BP 3 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1548873 | Acnefree BP 3 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1548873 | Acnefree BP 3 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 154904 | AQP family protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154904 | AQP family protein | Designated preferred name (PT) | NO | |
| RxCUI: 154904 | AQP family protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154904 | AQP family protein | Full form of descriptor (FN) | NO | |
| RxCUI: 154906 | nicotine Chewing Gum | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1549079 | glycerin 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549080 | glycerin Medicated Liquid Soap | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1549081 | glycerin 1 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549081 | glycerin 1 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549082 | ivermectin 5 MG/ML [Promectin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549083 | ivermectin Topical Solution [Promectin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1549084 | Promectin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549085 | Promectin 5 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549085 | Promectin 5 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549085 | Promectin 5 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549086 | Opcicon One-Step | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1549087 | levonorgestrel 1.5 MG [Opcicon One-Step] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1549088 | levonorgestrel Oral Tablet [Opcicon One-Step] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1549089 | Opcicon One-Step Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1549090 | Opcicon One-Step Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1549091 | Opcicon One-Step 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1549091 | Opcicon One-Step 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549091 | Opcicon One-Step 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549092 | petrolatum 0.997 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549093 | petrolatum 99.7 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549093 | petrolatum 99.7 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549093 | petrolatum 99.7 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549094 | salicylic acid 15 MG/ML [Acnefree SA] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549095 | salicylic acid Medicated Liquid Soap [Acnefree SA] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1549096 | Acnefree SA Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549097 | Acnefree SA 1.5 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549097 | Acnefree SA 1.5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549097 | Acnefree SA 1.5 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549098 | benzoyl peroxide 3 % Topical Lotion (59 ML) / salicylic acid 1.5 % Medicated Liquid Soap (118 ML) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1549098 | benzoyl peroxide 3 % Topical Lotion (59 ML) / salicylic acid 1.5 % Medicated Liquid Soap (118 ML) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549099 | Acnefree Sensitive Acne Clearing System Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1549099 | Acnefree Sensitive Acne Clearing System Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549099 | Acnefree Sensitive Acne Clearing System Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549102 | Bos taurus artery preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549103 | Hyacinthus orientalis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549104 | lead sulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549105 | Leonurus cardiaca flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549106 | levomefolate magnesium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1549107 | Lysimachia nummularia extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549108 | Picea abies leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549109 | platinic chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549110 | silver sulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549111 | Teucrium scorodonia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549112 | threonic acid, L- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1549113 | magnesium L-threonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1549114 | zinc ascorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549115 | 1,2-docosahexanoyl-sn-glycero-3-phosphoserine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549116 | 1,2-docosahexanoyl-sn-glycero-3-phosphoserine calcium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549117 | 1,2-icosapentoyl-sn-glycero-3-phosphoserine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549118 | 1,2-icosapentoyl-sn-glycero-3-phosphoserine calcium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549124 | zinc pyrithione Topical Lotion [Biokera] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1549125 | Biokera Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549126 | Biokera 0.1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549126 | Biokera 0.1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549126 | Biokera 0.1 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549138 | piperazine sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1549139 | sodium fluoride 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 154914 | Substance with antiretroviral mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 154914 | Substance with antiretroviral mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 154914 | Substance with antiretroviral mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 154914 | Substance with antiretroviral mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154914 | Substance with antiretroviral mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1549140 | Sodium Fluoride 0.1 MG/ML Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549140 | Sodium Fluoride 0.1 MG/ML Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549143 | polixetonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549152 | methyl salicylate 230 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549153 | methyl salicylate Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1549154 | methyl salicylate 23 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549154 | methyl salicylate 23 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549155 | Aspi-Rub | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1549156 | methyl salicylate 230 MG/ML [Aspi-Rub] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549157 | methyl salicylate Topical Spray [Aspi-Rub] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1549158 | Aspi-Rub Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549159 | Aspi-Rub Pain Reliever 23 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549159 | Aspi-Rub Pain Reliever 23 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549159 | Aspi-Rub Pain Reliever 23 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549159 | Aspi-Rub Pain Reliever 23 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549204 | Acnefree BP 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549204 | Acnefree BP 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549204 | Acnefree BP 10 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549205 | benzoyl peroxide 50 MG/ML [Acnefree BP] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549206 | Acnefree BP 5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549206 | Acnefree BP 5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549206 | Acnefree BP 5 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549208 | chlorhexidine / miconazole Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1549209 | chlorhexidine / miconazole Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1549210 | chlorhexidine gluconate 0.2 % / miconazole nitrate 0.2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549210 | chlorhexidine gluconate 0.2 % / miconazole nitrate 0.2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549210 | chlorhexidine gluconate 0.2 % / miconazole nitrate 0.2 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549212 | chlorhexidine / miconazole Topical Solution [Malaseb] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1549213 | Malaseb Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549214 | Malaseb 0.2 % / 0.2 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549214 | Malaseb 0.2 % / 0.2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549214 | Malaseb 0.2 % / 0.2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549223 | lidocaine 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549223 | lidocaine 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549223 | lidocaine 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549224 | Citrus maxima fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549225 | Impatiens balsamina flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549226 | doconexent 350 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549227 | doconexent Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1549228 | doconexent Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1549229 | doconexent Delayed Release Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1549230 | doconexent 350 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549230 | doconexent 350 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549231 | sulfamethoxazole 1.67 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549232 | trimethoprim 0.333 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549233 | sulfamethoxazole 400 MG / trimethoprim 80 MG in 240 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549233 | sulfamethoxazole 400 MG / trimethoprim 80 MG in 240 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549233 | sulfamethoxazole 400 MG / trimethoprim 80 MG in 240 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549233 | sulfamethoxazole 400 MG / trimethoprim 80 MG in 240 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549302 | miconazole nitrate 2 % / salicylic acid 2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549302 | miconazole nitrate 2 % / salicylic acid 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549302 | miconazole nitrate 2 % / salicylic acid 2 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549303 | miconazole nitrate 20 MG/ML / salicylic acid 20 MG/ML [Dermazole] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549304 | Dermazole 2 % / 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549304 | Dermazole 2 % / 2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549304 | Dermazole 2 % / 2 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549305 | triclosan / zinc oxide Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1549306 | triclosan / zinc oxide Topical Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1549307 | triclosan / zinc oxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1549308 | triclosan 0.1 % / zinc oxide 10.8 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549308 | triclosan 0.1 % / zinc oxide 10.8 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549308 | triclosan 0.1 % / zinc oxide 10.8 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549308 | triclosan 0.1 % / zinc oxide 10.8 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549311 | miconazole Powder Spray [Ting AF] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1549312 | Ting AF 2 % Powder Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1549312 | Ting AF 2 % Powder Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549312 | Ting AF 2 % Powder Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549312 | Ting AF 2 % Powder Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549314 | prednisolone acetate 1.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549314 | prednisolone acetate 1.25 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1549315 | prednisoLONE acetate 0.125 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549315 | prednisoLONE acetate 0.125 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549315 | prednisoLONE acetate 0.125 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1549315 | prednisoLONE acetate 0.125 % Ophthalmic Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 1549315 | prednisoLONE acetate 0.125 % Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549315 | prednisoLONE acetate 0.125 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1549315 | prednisoLONE acetate 0.125 % Ophthalmic Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 1549316 | prednisolone acetate 1.25 MG/ML [Econopred] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549316 | prednisolone acetate 1.25 MG/ML [Econopred] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1549317 | Econopred 0.125 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549317 | Econopred 0.125 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549317 | Econopred 0.125 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549317 | Econopred 0.125 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549317 | Econopred 0.125 % Ophthalmic Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1549323 | pegvisomant 25 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549323 | pegvisomant 25 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1549324 | Head & Shoulders Clinical Strength | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1549325 | selenium sulfide 10 MG/ML [Head & Shoulders Clinical Strength] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549326 | selenium sulfide Medicated Shampoo [Head & Shoulders Clinical Strength] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1549327 | Head & Shoulders Clinical Strength Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549328 | Head & Shoulders Clinical Strength 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549328 | Head & Shoulders Clinical Strength 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549328 | Head & Shoulders Clinical Strength 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549328 | Head & Shoulders Clinical Strength 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549328 | Head & Shoulders Clinical Strength 1 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549329 | blueberry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1549330 | Coccidioides immitis spherule | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1549331 | rosin partially dimerized glycerol ester | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549332 | selenocysteine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549336 | cetirizine Oral Capsule [Wal-Zyr] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1549337 | Wal-Zyr 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1549337 | Wal-Zyr 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549337 | Wal-Zyr 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549352 | Caldesene w/ Talc | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1549353 | talc 0.81 MG/MG / zinc oxide 0.15 MG/MG [Caldesene w/ Talc] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549354 | talc / zinc oxide Topical Powder [Caldesene w/ Talc] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1549355 | Caldesene w/ Talc Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549356 | Caldesene 81 % / 15 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549356 | Caldesene 81 % / 15 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549356 | Caldesene 81 % / 15 % Topical Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549356 | Caldesene 81 % / 15 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549366 | xylometazoline hydrochloride 0.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549367 | xylometazoline HCl 0.05 % Nasal Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 1549367 | xylometazoline HCl 0.05 % Nasal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549367 | xylometazoline HCl 0.05 % Nasal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549367 | xylometazoline HCl 0.05 % Nasal Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549367 | xylometazoline HCl 0.05 % Nasal Solution | Designated preferred name (PT) | NO | |
| RxCUI: 1549368 | xylometazoline hydrochloride 0.5 MG/ML [Otrivin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549369 | Otrivin 0.05 % Nasal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549369 | Otrivin 0.05 % Nasal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549369 | Otrivin 0.05 % Nasal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549369 | Otrivin 0.05 % Nasal Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549372 | xylometazoline HCl 0.1 % Nasal Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 1549372 | xylometazoline HCl 0.1 % Nasal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549372 | xylometazoline HCl 0.1 % Nasal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549372 | xylometazoline HCl 0.1 % Nasal Solution | Designated preferred name (PT) | NO | |
| RxCUI: 1549372 | xylometazoline HCl 0.1 % Nasal Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549386 | phenylephrine HCl 0.125 % Nasal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549386 | phenylephrine HCl 0.125 % Nasal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549386 | phenylephrine HCl 0.125 % Nasal Solution | Designated preferred name (PT) | YES | |
| RxCUI: 1549386 | phenylephrine HCl 0.125 % Nasal Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1549386 | phenylephrine HCl 0.125 % Nasal Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 1549387 | phenylephrine hydrochloride 1.25 MG/ML [Little Noses Decongestant] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1549388 | Little Noses Decongestant 0.125 % Nasal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549388 | Little Noses Decongestant 0.125 % Nasal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549388 | Little Noses Decongestant 0.125 % Nasal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549388 | Little Noses Decongestant 0.125 % Nasal Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1549390 | Otrivin 0.1 % Nasal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549390 | Otrivin 0.1 % Nasal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549390 | Otrivin 0.1 % Nasal Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549391 | phenylephrine HCl 0.17 % Nasal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549391 | phenylephrine HCl 0.17 % Nasal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549391 | phenylephrine HCl 0.17 % Nasal Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549395 | Substance with Janus kinase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1549395 | Substance with Janus kinase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1549395 | Substance with Janus kinase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1549395 | Substance with Janus kinase inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549395 | Substance with Janus kinase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1549397 | chloroxylenol 1 MG / benzocaine 15 MG / hydrocortisone acetate 10 MG per ML Otic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549397 | chloroxylenol 1 MG / benzocaine 15 MG / hydrocortisone acetate 10 MG per ML Otic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549397 | chloroxylenol 1 MG / benzocaine 15 MG / hydrocortisone acetate 10 MG per ML Otic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549398 | benzocaine 15 MG/ML / chloroxylenol 1 MG/ML / hydrocortisone acetate 10 MG/ML [Myoxin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549399 | MyOxin 1 MG / 15 MG / 10 MG per ML Otic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549399 | MyOxin 1 MG / 15 MG / 10 MG per ML Otic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549399 | MyOxin 1 MG / 15 MG / 10 MG per ML Otic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549400 | lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG [Puroxcin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549401 | lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG Medicated Patch [Puroxcin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549401 | lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG Medicated Patch [Puroxcin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549402 | benzocaine 15 MG/ML / chloroxylenol 1 MG/ML / hydrocortisone acetate 10 MG/ML [TriOxin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549403 | TriOxin 1 MG / 15 MG / 10 MG per ML Otic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549403 | TriOxin 1 MG / 15 MG / 10 MG per ML Otic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549403 | TriOxin 1 MG / 15 MG / 10 MG per ML Otic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549404 | gentamicin (as gentamicin sulfate) 3 MG/ML / hydrocortisone acetate 10 MG/ML Otic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549404 | gentamicin (as gentamicin sulfate) 3 MG/ML / hydrocortisone acetate 10 MG/ML Otic Suspension | Designated preferred name (PT) | NO | |
| RxCUI: 1549404 | gentamicin (as gentamicin sulfate) 3 MG/ML / hydrocortisone acetate 10 MG/ML Otic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549404 | gentamicin (as gentamicin sulfate) 3 MG/ML / hydrocortisone acetate 10 MG/ML Otic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549404 | gentamicin (as gentamicin sulfate) 3 MG/ML / hydrocortisone acetate 10 MG/ML Otic Suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 1549423 | amylase 218000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549424 | protease 136000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549425 | lipase 40000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1549426 | lipase 40,000 UNT / amylase 218,000 UNT / protease 136,000 UNT Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549426 | lipase 40,000 UNT / amylase 218,000 UNT / protease 136,000 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549426 | lipase 40,000 UNT / amylase 218,000 UNT / protease 136,000 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549427 | amylase 218000 UNT / lipase 40000 UNT / protease 136000 UNT [Zenpep] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549428 | Zenpep 40,000 UNT / 218,000 UNT / 136,000 UNT Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549428 | Zenpep 40,000 UNT / 218,000 UNT / 136,000 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549428 | Zenpep 40,000 UNT / 218,000 UNT / 136,000 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549428 | Zenpep 40,000 UNT / 218,000 UNT / 136,000 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549428 | Zenpep 40,000 UNT / 218,000 UNT / 136,000 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549429 | Kenocidin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1549430 | chlorhexidine gluconate 5 MG/ML [Kenocidin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549431 | chlorhexidine Topical Spray [Kenocidin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1549432 | Kenocidin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549433 | Kenocidin 0.5 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549433 | Kenocidin 0.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549433 | Kenocidin 0.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549434 | chlorhexidine Topical Solution [Kenocidin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1549435 | Kenocidin 0.5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549435 | Kenocidin 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549435 | Kenocidin 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549437 | Pet Pectillin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1549440 | Pet Pectillin Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549441 | Pet Pectillin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549443 | Glydo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1549444 | lidocaine hydrochloride 0.02 MG/MG [Glydo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1549445 | lidocaine Topical Gel [Glydo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1549446 | Glydo Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1549447 | Glydo 2 % Topical Jelly | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549447 | Glydo 2 % Topical Jelly | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549447 | Glydo 2 % Topical Jelly | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1549452 | pegvisomant 30 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549452 | pegvisomant 30 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1549452 | pegvisomant 30 MG Injection | Designated preferred name (PT) | YES | |
| RxCUI: 1549452 | pegvisomant 30 MG Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 1549454 | Somavert 30 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1549454 | Somavert 30 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549454 | Somavert 30 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549456 | Somavert 25 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1549456 | Somavert 25 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549456 | Somavert 25 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549457 | estradiol 3-benzoate 21 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549458 | trenbolone acetate 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549459 | estradiol / trenbolone Drug Implant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1549460 | estradiol / trenbolone Drug Implant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1549461 | estradiol / trenbolone | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1549462 | trenbolone acetate 150 MG / estradiol benzoate 21 MG Drug Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549462 | trenbolone acetate 150 MG / estradiol benzoate 21 MG Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549462 | trenbolone acetate 150 MG / estradiol benzoate 21 MG Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549468 | estradiol 3-benzoate 28 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549469 | trenbolone acetate 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549470 | trenbolone acetate 200 MG / estradiol benzoate 28 MG Drug Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549470 | trenbolone acetate 200 MG / estradiol benzoate 28 MG Drug Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549470 | trenbolone acetate 200 MG / estradiol benzoate 28 MG Drug Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549473 | hydrocortisone acetate 15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549474 | hydrocortisone acetate 1.5 % / neomycin sulfate 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549474 | hydrocortisone acetate 1.5 % / neomycin sulfate 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549474 | hydrocortisone acetate 1.5 % / neomycin sulfate 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549474 | hydrocortisone acetate 1.5 % / neomycin sulfate 0.5 % Ophthalmic Solution | Designated preferred name (PT) | NO | |
| RxCUI: 1549474 | hydrocortisone acetate 1.5 % / neomycin sulfate 0.5 % Ophthalmic Solution | Full form of descriptor (FN) | NO | |
| RxCUI: 1549484 | lidocaine 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549484 | lidocaine 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549484 | lidocaine 1 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 154951 | Dioxygenase | Designated preferred name (PT) | NO | |
| RxCUI: 154951 | Dioxygenase | Full form of descriptor (FN) | NO | |
| RxCUI: 1549532 | benzethonium / dimethicone Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1549533 | benzethonium chloride 0.2 % / dimethicone 2 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549533 | benzethonium chloride 0.2 % / dimethicone 2 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549538 | GentaVed Otic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549539 | GentaVed 3 MG / 1 MG in 1 ML Otic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549539 | GentaVed 3 MG / 1 MG in 1 ML Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549539 | GentaVed 3 MG / 1 MG in 1 ML Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549540 | Dihydrostreptomycin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549540 | Dihydrostreptomycin | Designated preferred name (PT) | NO | |
| RxCUI: 1549540 | Dihydrostreptomycin | Full form of descriptor (FN) | NO | |
| RxCUI: 1549540 | Dihydrostreptomycin | Designated preferred name (PT) | NO | |
| RxCUI: 1549540 | Dihydrostreptomycin | Full form of descriptor (FN) | NO | |
| RxCUI: 1549541 | dihydrostreptomycin 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549542 | penicillin G procaine 100000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549543 | dihydrostreptomycin / penicillin G Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1549544 | dihydrostreptomycin / penicillin G Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1549545 | dihydrostreptomycin / penicillin G | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1549546 | dihydrostreptomycin (as dihydrostreptomycin sulfate) 1 GM / penicillin G procaine 1,000,000 UNT per 10 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549546 | dihydrostreptomycin (as dihydrostreptomycin sulfate) 1 GM / penicillin G procaine 1,000,000 UNT per 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549547 | Quartermaster | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1549548 | dihydrostreptomycin 100 MG/ML / penicillin G procaine 100000 UNT/ML [Quartermaster] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549549 | dihydrostreptomycin / penicillin G Prefilled Syringe [Quartermaster] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1549550 | Quartermaster Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549551 | 10 ML dihydrostreptomycin 100 MG/ML / penicillin G procaine 100000 UNT/ML Prefilled Syringe [Quartermaster] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549551 | 10 ML dihydrostreptomycin 100 MG/ML / penicillin G procaine 100000 UNT/ML Prefilled Syringe [Quartermaster] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549552 | dihydrostreptomycin 100 MG/ML / penicillin G procaine 100000 UNT/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549553 | dihydrostreptomycin 100 MG/ML / penicillin G procaine 100000 UNT/ML Prefilled Syringe [Quartermaster] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549554 | Alisma plantago-aquatica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549555 | barium iodate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549556 | Dihydrostreptomycin sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1549556 | Dihydrostreptomycin sulfate | Designated preferred name (PT) | NO | |
| RxCUI: 1549556 | Dihydrostreptomycin sulfate | Full form of descriptor (FN) | NO | |
| RxCUI: 1549556 | Dihydrostreptomycin sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549557 | diphenhydrAMINE Disintegrating Oral Tablet [Wal-Sleep Z] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1549557 | diphenhydrAMINE Disintegrating Oral Tablet [Wal-Sleep Z] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1549558 | Wal-Sleep Z Disintegrating Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1549559 | Wal-Sleep Z 25 MG Disintegrating Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1549559 | Wal-Sleep Z 25 MG Disintegrating Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1549559 | Wal-Sleep Z 25 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549559 | Wal-Sleep Z 25 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549613 | chloroxylenol 0.2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549613 | chloroxylenol 0.2 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549614 | Dermakleen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1549615 | chloroxylenol 2 MG/ML [Dermakleen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549616 | chloroxylenol Medicated Liquid Soap [Dermakleen] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1549617 | Dermakleen Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549618 | Dermakleen 0.2 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549618 | Dermakleen 0.2 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549618 | Dermakleen 0.2 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549620 | camphor 0.1 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549620 | camphor 0.1 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549620 | camphor 0.1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549627 | Perigiene | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1549628 | chloroxylenol 5 MG/ML [Perigiene] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1549629 | chloroxylenol Medicated Liquid Soap [Perigiene] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1549630 | Perigiene Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1549631 | Perigiene 0.5 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1549631 | Perigiene 0.5 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549631 | Perigiene 0.5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549632 | hydroxyethyl cetyldimonium phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1549633 | Abies alba leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1549678 | enflurane 99.9 % Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549678 | enflurane 99.9 % Inhalation Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1549678 | enflurane 99.9 % Inhalation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549678 | enflurane 99.9 % Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549678 | enflurane 99.9 % Inhalation Solution | Designated preferred name (PT) | YES | |
| RxCUI: 1549678 | enflurane 99.9 % Inhalation Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 1549680 | enflurane 1000 MG/ML Inhalation Solution [Ethrane] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549680 | enflurane 1000 MG/ML Inhalation Solution [Ethrane] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549680 | enflurane 1000 MG/ML Inhalation Solution [Ethrane] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549682 | rivaroxaban 30-Day Starter Pack (42-15 MG Oral Tablets & 9-20 MG Oral Tablets) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1549682 | rivaroxaban 30-Day Starter Pack (42-15 MG Oral Tablets & 9-20 MG Oral Tablets) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549682 | rivaroxaban 30-Day Starter Pack (42-15 MG Oral Tablets & 9-20 MG Oral Tablets) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549683 | Xarelto Starter Pack, 30-Day | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1549683 | Xarelto Starter Pack, 30-Day | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549683 | Xarelto Starter Pack, 30-Day | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549687 | immunoglobulin G, human 30 GM / hyaluronidase, human recombinant 2400 UNT Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1549687 | immunoglobulin G, human 30 GM / hyaluronidase, human recombinant 2400 UNT Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549687 | immunoglobulin G, human 30 GM / hyaluronidase, human recombinant 2400 UNT Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549688 | HYQVIA 30 GM / 300 ML Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1549688 | HYQVIA 30 GM / 300 ML Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549688 | HYQVIA 30 GM / 300 ML Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549689 | immunoglobulin G, human 2.5 GM / hyaluronidase, human recombinant 200 UNT Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1549689 | immunoglobulin G, human 2.5 GM / hyaluronidase, human recombinant 200 UNT Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549690 | HYQVIA 2.5 GM / 25 ML Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1549690 | HYQVIA 2.5 GM / 25 ML Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549690 | HYQVIA 2.5 GM / 25 ML Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549691 | immunoglobulin G, human 5 GM / hyaluronidase, human recombinant 400 UNT Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1549691 | immunoglobulin G, human 5 GM / hyaluronidase, human recombinant 400 UNT Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549692 | HYQVIA 5 GM / 50 ML Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1549692 | HYQVIA 5 GM / 50 ML Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549692 | HYQVIA 5 GM / 50 ML Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549693 | immunoglobulin G, human 10 GM / hyaluronidase, human recombinant 800 UNT Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1549693 | immunoglobulin G, human 10 GM / hyaluronidase, human recombinant 800 UNT Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549694 | HYQVIA 10 GM / 100 ML Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1549694 | HYQVIA 10 GM / 100 ML Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549694 | HYQVIA 10 GM / 100 ML Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549695 | immunoglobulin G, human 20 GM / hyaluronidase, human recombinant 1600 UNT Kit | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1549695 | immunoglobulin G, human 20 GM / hyaluronidase, human recombinant 1600 UNT Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549696 | HYQVIA 20 GM / 200 ML Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1549696 | HYQVIA 20 GM / 200 ML Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549696 | HYQVIA 20 GM / 200 ML Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549697 | Ribes nigrum flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1549698 | immunoglobulin G, human 100 MG/ML [Octagam] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1549701 | oxyquinoline Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1549702 | oxyquinoline 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549702 | oxyquinoline 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549705 | zinc gluconate 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549706 | zinc gluconate Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1549707 | zinc gluconate Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1549708 | zinc gluconate 1 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549708 | zinc gluconate 1 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549713 | Calmodrox | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1549714 | menthol 0.0044 MG/MG / zinc oxide 0.2 MG/MG [Calmodrox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549715 | menthol / zinc oxide Topical Ointment [Calmodrox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1549716 | Calmodrox Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549717 | menthol 0.0044 MG/MG / zinc oxide 0.2 MG/MG Topical Ointment [Calmodrox] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549717 | menthol 0.0044 MG/MG / zinc oxide 0.2 MG/MG Topical Ointment [Calmodrox] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 154978 | Largactil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 154982 | Ubretid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1549827 | oritavancin diphosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1549828 | Somnasol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1549829 | pentobarbital sodium 390 MG/ML / phenytoin sodium 50 MG/ML [Somnasol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549829 | pentobarbital sodium 390 MG/ML / phenytoin sodium 50 MG/ML [Somnasol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1549830 | pentobarbital / phenytoin Injectable Solution [Somnasol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1549830 | pentobarbital / phenytoin Injectable Solution [Somnasol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1549831 | Somnasol Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549832 | pentobarbital sodium 390 MG/ML / phenytoin sodium 50 MG/ML Injectable Solution [Somnasol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549832 | pentobarbital sodium 390 MG/ML / phenytoin sodium 50 MG/ML Injectable Solution [Somnasol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1549832 | pentobarbital sodium 390 MG/ML / phenytoin sodium 50 MG/ML Injectable Solution [Somnasol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549832 | pentobarbital sodium 390 MG/ML / phenytoin sodium 50 MG/ML Injectable Solution [Somnasol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1549832 | pentobarbital sodium 390 MG/ML / phenytoin sodium 50 MG/ML Injectable Solution [Somnasol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549832 | pentobarbital sodium 390 MG/ML / phenytoin sodium 50 MG/ML Injectable Solution [Somnasol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 154984 | Benoral | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1549849 | menthol 0.046 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 154985 | Nalbuphine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 154985 | Nalbuphine hydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 154985 | Nalbuphine hydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 1549850 | menthol 4.6 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549850 | menthol 4.6 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549850 | menthol 4.6 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549851 | Eye Stream | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1549852 | water 986 MG/ML [Eye Stream] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1549853 | water Ophthalmic Irrigation Solution [Eye Stream] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1549854 | Eye Stream Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1549855 | eye stream 98.6 % Ophthalmic Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549855 | eye stream 98.6 % Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549855 | eye stream 98.6 % Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1549855 | eye stream 98.6 % Ophthalmic Irrigation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1549859 | IsoSol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1549860 | isoflurane 999 MG/ML [IsoSol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1549862 | IsoSol Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1549863 | IsoSol 99.9 % Inhalation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1549863 | IsoSol 99.9 % Inhalation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549863 | IsoSol 99.9 % Inhalation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549866 | benzalkonium chloride 5.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549867 | benzalkonium chloride 0.55 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549867 | benzalkonium chloride 0.55 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549867 | benzalkonium chloride 0.55 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 154987 | hydroxyzine dihydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 154987 | hydroxyzine dihydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 154987 | hydroxyzine dihydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 154987 | hydroxyzine dihydrochloride | Designated preferred name (PT) | YES | |
| RxCUI: 154987 | hydroxyzine dihydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 154987 | hydroxyzine dihydrochloride | Full form of descriptor (FN) | YES | |
| RxCUI: 1549874 | myristic diisopropanolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 154988 | Calcium-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 154988 | Calcium-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 154990 | Buspar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 154991 | Renitec | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 154992 | Mexitil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 154993 | Acupan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 154995 | Slow Trasicor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1549965 | docosahexaenoic acid 350 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1549965 | docosahexaenoic acid 350 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1549966 | calcium carbonate 1000 MG / magnesium hydroxide 200 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1549966 | calcium carbonate 1000 MG / magnesium hydroxide 200 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549966 | calcium carbonate 1000 MG / magnesium hydroxide 200 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549969 | glucose 68 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549970 | dextrose 6.8 GM / 100 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549970 | dextrose 6.8 GM / 100 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549970 | dextrose 6.8 GM / 100 ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1549971 | glucose 98 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1549972 | dextrose 9.8 GM / 100 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549972 | dextrose 9.8 GM / 100 ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1549972 | dextrose 9.8 GM / 100 ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |